CN112118823B - 包含氟离子的口腔护理组合物 - Google Patents
包含氟离子的口腔护理组合物 Download PDFInfo
- Publication number
- CN112118823B CN112118823B CN201980032396.9A CN201980032396A CN112118823B CN 112118823 B CN112118823 B CN 112118823B CN 201980032396 A CN201980032396 A CN 201980032396A CN 112118823 B CN112118823 B CN 112118823B
- Authority
- CN
- China
- Prior art keywords
- oral care
- care composition
- composition
- fluoride
- source
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 583
- -1 fluoride ions Chemical class 0.000 title claims abstract description 85
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims abstract description 63
- 239000000463 material Substances 0.000 claims abstract description 63
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims abstract description 38
- 229910001424 calcium ion Inorganic materials 0.000 claims abstract description 38
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 33
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000011737 fluorine Substances 0.000 claims abstract description 29
- 229940091249 fluoride supplement Drugs 0.000 claims description 70
- 229910021645 metal ion Inorganic materials 0.000 claims description 35
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims description 32
- 239000003082 abrasive agent Substances 0.000 claims description 24
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 20
- 239000011575 calcium Substances 0.000 claims description 19
- 229910001432 tin ion Inorganic materials 0.000 claims description 19
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 claims description 18
- 229910052791 calcium Inorganic materials 0.000 claims description 17
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 16
- 239000011775 sodium fluoride Substances 0.000 claims description 16
- 235000013024 sodium fluoride Nutrition 0.000 claims description 16
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 14
- 229960002799 stannous fluoride Drugs 0.000 claims description 12
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 10
- 229960000414 sodium fluoride Drugs 0.000 claims description 8
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 claims description 7
- 159000000007 calcium salts Chemical class 0.000 claims description 7
- 229960004711 sodium monofluorophosphate Drugs 0.000 claims description 7
- 229960001245 olaflur Drugs 0.000 claims 4
- ZVVSSOQAYNYNPP-UHFFFAOYSA-N olaflur Chemical compound F.F.CCCCCCCCCCCCCCCCCCN(CCO)CCCN(CCO)CCO ZVVSSOQAYNYNPP-UHFFFAOYSA-N 0.000 claims 4
- 239000000835 fiber Substances 0.000 abstract description 90
- 239000000306 component Substances 0.000 description 63
- 239000000551 dentifrice Substances 0.000 description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 47
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 39
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 38
- 239000010410 layer Substances 0.000 description 34
- 229920000642 polymer Polymers 0.000 description 32
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 31
- 229920000388 Polyphosphate Polymers 0.000 description 27
- 210000003298 dental enamel Anatomy 0.000 description 27
- 239000001205 polyphosphate Substances 0.000 description 27
- 235000011176 polyphosphates Nutrition 0.000 description 27
- 239000003795 chemical substances by application Substances 0.000 description 24
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 24
- 239000002738 chelating agent Substances 0.000 description 23
- 239000000796 flavoring agent Substances 0.000 description 23
- 210000000214 mouth Anatomy 0.000 description 23
- 239000004094 surface-active agent Substances 0.000 description 23
- 239000006260 foam Substances 0.000 description 22
- 239000006072 paste Substances 0.000 description 21
- 239000004615 ingredient Substances 0.000 description 20
- 239000007787 solid Substances 0.000 description 19
- 229910019142 PO4 Inorganic materials 0.000 description 18
- 235000021317 phosphate Nutrition 0.000 description 18
- 235000019634 flavors Nutrition 0.000 description 17
- 238000000034 method Methods 0.000 description 17
- 239000008199 coating composition Substances 0.000 description 16
- 150000001875 compounds Chemical class 0.000 description 15
- 239000008367 deionised water Substances 0.000 description 15
- 229910021641 deionized water Inorganic materials 0.000 description 15
- 239000000126 substance Substances 0.000 description 15
- 230000009257 reactivity Effects 0.000 description 14
- 150000003839 salts Chemical class 0.000 description 14
- 239000000377 silicon dioxide Substances 0.000 description 14
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 13
- 229920001223 polyethylene glycol Polymers 0.000 description 13
- 238000003756 stirring Methods 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 239000002202 Polyethylene glycol Substances 0.000 description 12
- 229960005069 calcium Drugs 0.000 description 12
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 12
- 239000010452 phosphate Substances 0.000 description 12
- 229920005862 polyol Polymers 0.000 description 12
- 150000003077 polyols Chemical class 0.000 description 12
- 239000002002 slurry Substances 0.000 description 12
- 239000008259 solid foam Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 229920002125 Sokalan® Polymers 0.000 description 11
- 235000003599 food sweetener Nutrition 0.000 description 11
- 150000002500 ions Chemical class 0.000 description 11
- 239000002324 mouth wash Substances 0.000 description 11
- 239000003765 sweetening agent Substances 0.000 description 11
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 11
- 239000001506 calcium phosphate Substances 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 235000000346 sugar Nutrition 0.000 description 10
- 125000000217 alkyl group Chemical group 0.000 description 9
- 235000011180 diphosphates Nutrition 0.000 description 9
- 238000004090 dissolution Methods 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 239000011734 sodium Substances 0.000 description 9
- 239000002562 thickening agent Substances 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 8
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 239000003945 anionic surfactant Substances 0.000 description 8
- 239000004599 antimicrobial Substances 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 229920001525 carrageenan Polymers 0.000 description 8
- 235000015165 citric acid Nutrition 0.000 description 8
- 239000003086 colorant Substances 0.000 description 8
- 229920001577 copolymer Polymers 0.000 description 8
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 229910052708 sodium Inorganic materials 0.000 description 8
- 229940083542 sodium Drugs 0.000 description 8
- 150000005846 sugar alcohols Chemical class 0.000 description 8
- 229910052725 zinc Inorganic materials 0.000 description 8
- 239000011701 zinc Substances 0.000 description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 7
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 7
- 229910001431 copper ion Inorganic materials 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 229940051866 mouthwash Drugs 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 239000004014 plasticizer Substances 0.000 description 7
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 7
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 7
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- 229910008449 SnF 2 Inorganic materials 0.000 description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
- 230000000975 bioactive effect Effects 0.000 description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 description 6
- 235000010216 calcium carbonate Nutrition 0.000 description 6
- 229910000389 calcium phosphate Inorganic materials 0.000 description 6
- 235000011010 calcium phosphates Nutrition 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 235000010418 carrageenan Nutrition 0.000 description 6
- 239000000679 carrageenan Substances 0.000 description 6
- 229940113118 carrageenan Drugs 0.000 description 6
- 229920002678 cellulose Polymers 0.000 description 6
- 239000001913 cellulose Substances 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 235000013355 food flavoring agent Nutrition 0.000 description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 229960001631 carbomer Drugs 0.000 description 5
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 239000002736 nonionic surfactant Substances 0.000 description 5
- 239000008188 pellet Substances 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 150000008163 sugars Chemical class 0.000 description 5
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 5
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 4
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- 229920000881 Modified starch Polymers 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 244000299461 Theobroma cacao Species 0.000 description 4
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 4
- 235000009499 Vanilla fragrans Nutrition 0.000 description 4
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 4
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 4
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 235000010443 alginic acid Nutrition 0.000 description 4
- 229920000615 alginic acid Polymers 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000001680 brushing effect Effects 0.000 description 4
- 239000001110 calcium chloride Substances 0.000 description 4
- 229910001628 calcium chloride Inorganic materials 0.000 description 4
- 235000011148 calcium chloride Nutrition 0.000 description 4
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 4
- 229910001634 calcium fluoride Inorganic materials 0.000 description 4
- 239000012482 calibration solution Substances 0.000 description 4
- 239000003093 cationic surfactant Substances 0.000 description 4
- 238000009833 condensation Methods 0.000 description 4
- 230000005494 condensation Effects 0.000 description 4
- 238000005115 demineralization Methods 0.000 description 4
- 230000002328 demineralizing effect Effects 0.000 description 4
- 238000000151 deposition Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 235000012907 honey Nutrition 0.000 description 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000011572 manganese Substances 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 150000002978 peroxides Chemical class 0.000 description 4
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000176 sodium gluconate Substances 0.000 description 4
- 235000012207 sodium gluconate Nutrition 0.000 description 4
- 229940005574 sodium gluconate Drugs 0.000 description 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 238000009987 spinning Methods 0.000 description 4
- 239000001119 stannous chloride Substances 0.000 description 4
- 235000011150 stannous chloride Nutrition 0.000 description 4
- 229920003179 starch-based polymer Polymers 0.000 description 4
- 239000004628 starch-based polymer Substances 0.000 description 4
- 229920001059 synthetic polymer Polymers 0.000 description 4
- 229910052718 tin Inorganic materials 0.000 description 4
- JTDNNCYXCFHBGG-UHFFFAOYSA-L tin(ii) iodide Chemical compound I[Sn]I JTDNNCYXCFHBGG-UHFFFAOYSA-L 0.000 description 4
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 4
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 4
- 239000011800 void material Substances 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 230000002087 whitening effect Effects 0.000 description 4
- 235000010447 xylitol Nutrition 0.000 description 4
- 239000000811 xylitol Substances 0.000 description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 4
- 229960002675 xylitol Drugs 0.000 description 4
- 239000011746 zinc citrate Substances 0.000 description 4
- 235000006076 zinc citrate Nutrition 0.000 description 4
- 229940068475 zinc citrate Drugs 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- BHHYHSUAOQUXJK-UHFFFAOYSA-L zinc fluoride Chemical compound F[Zn]F BHHYHSUAOQUXJK-UHFFFAOYSA-L 0.000 description 4
- 239000011670 zinc gluconate Substances 0.000 description 4
- 235000011478 zinc gluconate Nutrition 0.000 description 4
- 229960000306 zinc gluconate Drugs 0.000 description 4
- 239000011576 zinc lactate Substances 0.000 description 4
- 235000000193 zinc lactate Nutrition 0.000 description 4
- 229940050168 zinc lactate Drugs 0.000 description 4
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 4
- 239000002888 zwitterionic surfactant Substances 0.000 description 4
- LMXFTMYMHGYJEI-IWSPIJDZSA-N (1R,2R,5R)-2-(1-hydroxy-1-methylethyl)-5-methylcyclohexanol Chemical compound C[C@@H]1CC[C@@H](C(C)(C)O)[C@H](O)C1 LMXFTMYMHGYJEI-IWSPIJDZSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- 241000167854 Bourreria succulenta Species 0.000 description 3
- 239000004132 Calcium polyphosphate Substances 0.000 description 3
- 108010076119 Caseins Proteins 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 3
- 206010012186 Delayed delivery Diseases 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 235000006679 Mentha X verticillata Nutrition 0.000 description 3
- 235000002899 Mentha suaveolens Nutrition 0.000 description 3
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 3
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 3
- 108010001441 Phosphopeptides Proteins 0.000 description 3
- 235000011034 Rubus glaucus Nutrition 0.000 description 3
- 235000009122 Rubus idaeus Nutrition 0.000 description 3
- 206010039424 Salivary hypersecretion Diseases 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 244000078534 Vaccinium myrtillus Species 0.000 description 3
- 244000263375 Vanilla tahitensis Species 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 235000010419 agar Nutrition 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 125000003342 alkenyl group Chemical group 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 229940075534 amino methacrylate copolymer Drugs 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 230000000675 anti-caries Effects 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 239000005313 bioactive glass Substances 0.000 description 3
- 235000019827 calcium polyphosphate Nutrition 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 235000019693 cherries Nutrition 0.000 description 3
- 235000019219 chocolate Nutrition 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 3
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 210000004268 dentin Anatomy 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 238000011978 dissolution method Methods 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 229940050410 gluconate Drugs 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 229940001447 lactate Drugs 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000019426 modified starch Nutrition 0.000 description 3
- 235000021096 natural sweeteners Nutrition 0.000 description 3
- 235000019533 nutritive sweetener Nutrition 0.000 description 3
- 229920001277 pectin Polymers 0.000 description 3
- 235000010987 pectin Nutrition 0.000 description 3
- 239000001814 pectin Substances 0.000 description 3
- 229920000193 polymethacrylate Polymers 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 208000026451 salivation Diseases 0.000 description 3
- 229940071089 sarcosinate Drugs 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 230000007928 solubilization Effects 0.000 description 3
- 238000005063 solubilization Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000000606 toothpaste Substances 0.000 description 3
- 229940034610 toothpaste Drugs 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 150000003752 zinc compounds Chemical class 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- TYIOVYZMKITKRO-UHFFFAOYSA-N 2-[hexadecyl(dimethyl)azaniumyl]acetate Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)CC([O-])=O TYIOVYZMKITKRO-UHFFFAOYSA-N 0.000 description 2
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 2
- MDVYIGJINBYKOM-UHFFFAOYSA-N 3-[[5-Methyl-2-(1-methylethyl)cyclohexyl]oxy]-1,2-propanediol Chemical compound CC(C)C1CCC(C)CC1OCC(O)CO MDVYIGJINBYKOM-UHFFFAOYSA-N 0.000 description 2
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 244000208874 Althaea officinalis Species 0.000 description 2
- 235000006576 Althaea officinalis Nutrition 0.000 description 2
- 229920000856 Amylose Polymers 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 240000003538 Chamaemelum nobile Species 0.000 description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- XTEGARKTQYYJKE-UHFFFAOYSA-M Chlorate Chemical compound [O-]Cl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-M 0.000 description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 241000675108 Citrus tangerina Species 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical class [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 2
- 235000017897 Cymbopogon citratus Nutrition 0.000 description 2
- 240000004784 Cymbopogon citratus Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- YIKYNHJUKRTCJL-UHFFFAOYSA-N Ethyl maltol Chemical compound CCC=1OC=CC(=O)C=1O YIKYNHJUKRTCJL-UHFFFAOYSA-N 0.000 description 2
- VUNOFAIHSALQQH-UHFFFAOYSA-N Ethyl menthane carboxamide Chemical compound CCNC(=O)C1CC(C)CCC1C(C)C VUNOFAIHSALQQH-UHFFFAOYSA-N 0.000 description 2
- 241000272185 Falco Species 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- 244000307700 Fragaria vesca Species 0.000 description 2
- 235000016623 Fragaria vesca Nutrition 0.000 description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 2
- 108010068370 Glutens Proteins 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 2
- 241000234295 Musa Species 0.000 description 2
- RWAXQWRDVUOOGG-UHFFFAOYSA-N N,2,3-Trimethyl-2-(1-methylethyl)butanamide Chemical compound CNC(=O)C(C)(C(C)C)C(C)C RWAXQWRDVUOOGG-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 239000004373 Pullulan Substances 0.000 description 2
- 229920001218 Pullulan Polymers 0.000 description 2
- 244000235659 Rubus idaeus Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000004376 Sucralose Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 240000007313 Tilia cordata Species 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- ZFOZVQLOBQUTQQ-UHFFFAOYSA-N Tributyl citrate Chemical compound CCCCOC(=O)CC(O)(C(=O)OCCCC)CC(=O)OCCCC ZFOZVQLOBQUTQQ-UHFFFAOYSA-N 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 2
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 2
- 244000077923 Vaccinium vitis idaea Species 0.000 description 2
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 235000021014 blueberries Nutrition 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 2
- 239000001527 calcium lactate Substances 0.000 description 2
- 235000011086 calcium lactate Nutrition 0.000 description 2
- 229960002401 calcium lactate Drugs 0.000 description 2
- ROPDWRCJTIRLTR-UHFFFAOYSA-L calcium metaphosphate Chemical compound [Ca+2].[O-]P(=O)=O.[O-]P(=O)=O ROPDWRCJTIRLTR-UHFFFAOYSA-L 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 235000013736 caramel Nutrition 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 2
- NFCRBQADEGXVDL-UHFFFAOYSA-M cetylpyridinium chloride monohydrate Chemical compound O.[Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NFCRBQADEGXVDL-UHFFFAOYSA-M 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical class OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- LMXFTMYMHGYJEI-HLTSFMKQSA-N cis-p-Menthane-3,8-diol Natural products C[C@@H]1CC[C@@H](C(C)(C)O)[C@@H](O)C1 LMXFTMYMHGYJEI-HLTSFMKQSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- GWFAVIIMQDUCRA-UHFFFAOYSA-L copper(ii) fluoride Chemical class [F-].[F-].[Cu+2] GWFAVIIMQDUCRA-UHFFFAOYSA-L 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 2
- 229940038472 dicalcium phosphate Drugs 0.000 description 2
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 2
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- 229940093503 ethyl maltol Drugs 0.000 description 2
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical compound CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 235000011087 fumaric acid Nutrition 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 239000000905 isomalt Substances 0.000 description 2
- 235000010439 isomalt Nutrition 0.000 description 2
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 2
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000000832 lactitol Substances 0.000 description 2
- 235000010448 lactitol Nutrition 0.000 description 2
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 2
- 229960003451 lactitol Drugs 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 235000018977 lysine Nutrition 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000001035 marshmallow Nutrition 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 2
- 230000004660 morphological change Effects 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 235000019423 pullulan Nutrition 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- QSRAJVGDWKFOGU-WBXIDTKBSA-N rebaudioside c Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]1(CC[C@H]2[C@@]3(C)[C@@H]([C@](CCC3)(C)C(=O)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)CC3)C(=C)C[C@]23C1 QSRAJVGDWKFOGU-WBXIDTKBSA-N 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- 239000008247 solid mixture Substances 0.000 description 2
- 230000003381 solubilizing effect Effects 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- BXOCHUWSGYYSFW-HVWOQQCMSA-N spilanthol Chemical compound C\C=C\C=C/CC\C=C\C(=O)NCC(C)C BXOCHUWSGYYSFW-HVWOQQCMSA-N 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 229940108184 stannous iodide Drugs 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019408 sucralose Nutrition 0.000 description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000007916 tablet composition Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- ZSUXOVNWDZTCFN-UHFFFAOYSA-L tin(ii) bromide Chemical compound Br[Sn]Br ZSUXOVNWDZTCFN-UHFFFAOYSA-L 0.000 description 2
- 235000015149 toffees Nutrition 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 229940078499 tricalcium phosphate Drugs 0.000 description 2
- 235000019731 tricalcium phosphate Nutrition 0.000 description 2
- IIYFAKIEWZDVMP-UHFFFAOYSA-N tridecane Chemical compound CCCCCCCCCCCCC IIYFAKIEWZDVMP-UHFFFAOYSA-N 0.000 description 2
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 235000019222 white chocolate Nutrition 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 239000011667 zinc carbonate Substances 0.000 description 2
- 235000004416 zinc carbonate Nutrition 0.000 description 2
- 229910000010 zinc carbonate Inorganic materials 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- UAYWVJHJZHQCIE-UHFFFAOYSA-L zinc iodide Chemical compound I[Zn]I UAYWVJHJZHQCIE-UHFFFAOYSA-L 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229960001763 zinc sulfate Drugs 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- ZYTMANIQRDEHIO-KXUCPTDWSA-N (-)-Isopulegol Natural products C[C@@H]1CC[C@@H](C(C)=C)[C@H](O)C1 ZYTMANIQRDEHIO-KXUCPTDWSA-N 0.000 description 1
- FPJRGEOLQICYQZ-FHLIZLRMSA-N (1r,2s,5r)-n-[4-(cyanomethyl)phenyl]-5-methyl-2-propan-2-ylcyclohexane-1-carboxamide Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1C(=O)NC1=CC=C(CC#N)C=C1 FPJRGEOLQICYQZ-FHLIZLRMSA-N 0.000 description 1
- YXTDAZMTQFUZHK-ZVGUSBNCSA-L (2r,3r)-2,3-dihydroxybutanedioate;tin(2+) Chemical compound [Sn+2].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O YXTDAZMTQFUZHK-ZVGUSBNCSA-L 0.000 description 1
- CKUJRAYMVVJDMG-IYEMJOQQSA-L (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;tin(2+) Chemical compound [Sn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O CKUJRAYMVVJDMG-IYEMJOQQSA-L 0.000 description 1
- UFSKIYBOKFBSOA-MLYSRARTSA-N (2r,3s,4s,5r)-2-(hydroxymethyl)-6-octadecoxyoxane-3,4,5-triol Chemical compound CCCCCCCCCCCCCCCCCCOC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UFSKIYBOKFBSOA-MLYSRARTSA-N 0.000 description 1
- LUAHEUHBAZYUOI-KVXMBEGHSA-N (2s,3r,4r,5r)-4-[(2r,3r,4r,5s,6r)-5-[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-1,2,3,5,6-pentol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@@H]([C@H](O)[C@@H](O)CO)[C@H](O)CO)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1 LUAHEUHBAZYUOI-KVXMBEGHSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- PAEMERHSTIDLSE-VEIQOZLZSA-N (3r,4s,5s,6r)-2-hexadecoxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound CCCCCCCCCCCCCCCCOC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PAEMERHSTIDLSE-VEIQOZLZSA-N 0.000 description 1
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 description 1
- XVOUMQNXTGKGMA-OWOJBTEDSA-N (E)-glutaconic acid Chemical compound OC(=O)C\C=C\C(O)=O XVOUMQNXTGKGMA-OWOJBTEDSA-N 0.000 description 1
- 239000001124 (E)-prop-1-ene-1,2,3-tricarboxylic acid Substances 0.000 description 1
- OQBLGYCUQGDOOR-UHFFFAOYSA-L 1,3,2$l^{2}-dioxastannolane-4,5-dione Chemical compound O=C1O[Sn]OC1=O OQBLGYCUQGDOOR-UHFFFAOYSA-L 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical compound NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 description 1
- VDNMIIDPBBCMTM-UHFFFAOYSA-N 2-(2-hydroxyethoxy)acetic acid Chemical compound OCCOCC(O)=O VDNMIIDPBBCMTM-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- FVBGFZNFXUIHNC-GRYCIOLGSA-N 2-[(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl]oxyethanol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OCCO FVBGFZNFXUIHNC-GRYCIOLGSA-N 0.000 description 1
- JQAGDVDTMKMJIR-UHFFFAOYSA-N 2-[2-(2-dodecoxyethoxy)ethoxy]ethyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCOCCOCCOCCOP(O)(O)=O JQAGDVDTMKMJIR-UHFFFAOYSA-N 0.000 description 1
- NPKLJZUIYWRNMV-UHFFFAOYSA-N 2-[decyl(dimethyl)azaniumyl]acetate Chemical compound CCCCCCCCCC[N+](C)(C)CC([O-])=O NPKLJZUIYWRNMV-UHFFFAOYSA-N 0.000 description 1
- HVYJSOSGTDINLW-UHFFFAOYSA-N 2-[dimethyl(octadecyl)azaniumyl]acetate Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CC([O-])=O HVYJSOSGTDINLW-UHFFFAOYSA-N 0.000 description 1
- KKMIHKCGXQMFEU-UHFFFAOYSA-N 2-[dimethyl(tetradecyl)azaniumyl]acetate Chemical compound CCCCCCCCCCCCCC[N+](C)(C)CC([O-])=O KKMIHKCGXQMFEU-UHFFFAOYSA-N 0.000 description 1
- NGOZDSMNMIRDFP-UHFFFAOYSA-N 2-[methyl(tetradecanoyl)amino]acetic acid Chemical compound CCCCCCCCCCCCCC(=O)N(C)CC(O)=O NGOZDSMNMIRDFP-UHFFFAOYSA-N 0.000 description 1
- JUFHABKBWMZXKL-UHFFFAOYSA-N 2-dodecoxyethyl dihydrogen phosphate Chemical class CCCCCCCCCCCCOCCOP(O)(O)=O JUFHABKBWMZXKL-UHFFFAOYSA-N 0.000 description 1
- NNPFZDMSNIETII-UHFFFAOYSA-N 2-hydroxyethyl 5-methyl-2-propan-2-ylcyclohexane-1-carboxylate Chemical compound CC(C)C1CCC(C)CC1C(=O)OCCO NNPFZDMSNIETII-UHFFFAOYSA-N 0.000 description 1
- LTPZLDNFECOIQY-UHFFFAOYSA-N 2-methyl-3-(1-methyl-4-propan-2-ylcyclohexyl)oxypropane-1,2-diol Chemical compound CC(C)C1CCC(C)(OCC(C)(O)CO)CC1 LTPZLDNFECOIQY-UHFFFAOYSA-N 0.000 description 1
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 1
- CZVSZIWEHBXGHQ-UHFFFAOYSA-N 3-(2-hydroxyphenyl)-6-(2-nitrophenyl)-1,4-dihydropyrimidin-2-one Chemical compound OC1=CC=CC=C1N1C(=O)NC(C=2C(=CC=CC=2)[N+]([O-])=O)=CC1 CZVSZIWEHBXGHQ-UHFFFAOYSA-N 0.000 description 1
- QIGJYVCQYDKYDW-UHFFFAOYSA-N 3-O-alpha-D-mannopyranosyl-D-mannopyranose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(CO)OC(O)C1O QIGJYVCQYDKYDW-UHFFFAOYSA-N 0.000 description 1
- MDVYIGJINBYKOM-IBSWDFHHSA-N 3-[(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl]oxypropane-1,2-diol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OCC(O)CO MDVYIGJINBYKOM-IBSWDFHHSA-N 0.000 description 1
- USYAMXSCYLGBPT-UHFFFAOYSA-L 3-carboxy-3-hydroxypentanedioate;tin(2+) Chemical compound [Sn+2].OC(=O)CC(O)(C([O-])=O)CC([O-])=O USYAMXSCYLGBPT-UHFFFAOYSA-L 0.000 description 1
- DARSINVAIIMSIF-UHFFFAOYSA-N 3-methyl-4-pyrrolidin-1-yl-2h-furan-5-one Chemical compound O=C1OCC(C)=C1N1CCCC1 DARSINVAIIMSIF-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- BLILOGGUTRWFNI-GRYCIOLGSA-N 4-[(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl]oxy-4-oxobutanoic acid Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)CCC(O)=O BLILOGGUTRWFNI-GRYCIOLGSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PZPXDAEZSA-N 4β-mannobiose Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-PZPXDAEZSA-N 0.000 description 1
- DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 description 1
- UZJGVXSQDRSSHU-UHFFFAOYSA-N 6-(1,3-dioxoisoindol-2-yl)hexaneperoxoic acid Chemical compound C1=CC=C2C(=O)N(CCCCCC(=O)OO)C(=O)C2=C1 UZJGVXSQDRSSHU-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- QZCLKYGREBVARF-UHFFFAOYSA-N Acetyl tributyl citrate Chemical compound CCCCOC(=O)CC(C(=O)OCCCC)(OC(C)=O)CC(=O)OCCCC QZCLKYGREBVARF-UHFFFAOYSA-N 0.000 description 1
- 244000298715 Actinidia chinensis Species 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 239000004377 Alitame Substances 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 235000010082 Averrhoa carambola Nutrition 0.000 description 1
- 240000006063 Averrhoa carambola Species 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 239000004343 Calcium peroxide Substances 0.000 description 1
- 235000005273 Canna coccinea Nutrition 0.000 description 1
- 240000008555 Canna flaccida Species 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- QCZAWDGAVJMPTA-RNFRBKRXSA-N ClC1=CC=CC(=N1)C1=NC(=NC(=N1)N[C@@H](C(F)(F)F)C)N[C@@H](C(F)(F)F)C Chemical compound ClC1=CC=CC(=N1)C1=NC(=NC(=N1)N[C@@H](C(F)(F)F)C)N[C@@H](C(F)(F)F)C QCZAWDGAVJMPTA-RNFRBKRXSA-N 0.000 description 1
- 239000005749 Copper compound Substances 0.000 description 1
- 229910021594 Copper(II) fluoride Inorganic materials 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000723382 Corylus Species 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical compound [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-CBPJZXOFSA-N D-Gulose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-CBPJZXOFSA-N 0.000 description 1
- WQZGKKKJIJFFOK-WHZQZERISA-N D-aldose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-WHZQZERISA-N 0.000 description 1
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 1
- LKDRXBCSQODPBY-JDJSBBGDSA-N D-allulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@H]1O LKDRXBCSQODPBY-JDJSBBGDSA-N 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 1
- FBPFZTCFMRRESA-ZXXMMSQZSA-N D-iditol Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-ZXXMMSQZSA-N 0.000 description 1
- HSNZZMHEPUFJNZ-QMTIVRBISA-N D-keto-manno-heptulose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)C(=O)CO HSNZZMHEPUFJNZ-QMTIVRBISA-N 0.000 description 1
- HAIWUXASLYEWLM-UHFFFAOYSA-N D-manno-Heptulose Natural products OCC1OC(O)(CO)C(O)C(O)C1O HAIWUXASLYEWLM-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 1
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-threitol Chemical compound OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 1
- YTBSYETUWUMLBZ-QWWZWVQMSA-N D-threose Chemical compound OC[C@@H](O)[C@H](O)C=O YTBSYETUWUMLBZ-QWWZWVQMSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000055850 Diospyros virginiana Species 0.000 description 1
- 229930186291 Dulcoside Natural products 0.000 description 1
- 240000000716 Durio zibethinus Species 0.000 description 1
- 235000006025 Durio zibethinus Nutrition 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010056474 Erythrosis Diseases 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 244000207620 Euterpe oleracea Species 0.000 description 1
- 235000012601 Euterpe oleracea Nutrition 0.000 description 1
- 102100039207 Exportin-T Human genes 0.000 description 1
- 239000001329 FEMA 3811 Substances 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 239000001776 FEMA 4720 Substances 0.000 description 1
- RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000745703 Homo sapiens Exportin-T Proteins 0.000 description 1
- 101000801619 Homo sapiens Long-chain-fatty-acid-CoA ligase ACSBG1 Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 description 1
- 229920001144 Hydroxy alpha sanshool Polymers 0.000 description 1
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 235000018481 Hylocereus undatus Nutrition 0.000 description 1
- 244000157072 Hylocereus undatus Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- OKPQBUWBBBNTOV-UHFFFAOYSA-N Kojibiose Natural products COC1OC(O)C(OC2OC(OC)C(O)C(O)C2O)C(O)C1O OKPQBUWBBBNTOV-UHFFFAOYSA-N 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VSOAQEOCSA-N L-altropyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-VSOAQEOCSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- HSNZZMHEPUFJNZ-UHFFFAOYSA-N L-galacto-2-Heptulose Natural products OCC(O)C(O)C(O)C(O)C(=O)CO HSNZZMHEPUFJNZ-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 229920002884 Laureth 4 Polymers 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 102100033564 Long-chain-fatty-acid-CoA ligase ACSBG1 Human genes 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 1
- XJCCHWKNFMUJFE-CGQAXDJHSA-N Maltotriitol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@@H]([C@H](O)[C@@H](O)CO)[C@H](O)CO)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 XJCCHWKNFMUJFE-CGQAXDJHSA-N 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 235000010804 Maranta arundinacea Nutrition 0.000 description 1
- 244000217433 Melampodium divaricatum Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 244000078639 Mentha spicata Species 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- KNVPMEZIMFVWMD-UHFFFAOYSA-N Menthyl pyrrolidone carboxylate Chemical compound CC(C)C1CCC(C)CC1OC(=O)N1C(=O)CCC1 KNVPMEZIMFVWMD-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 239000004384 Neotame Substances 0.000 description 1
- MXRIRQGCELJRSN-UHFFFAOYSA-N O.O.O.[Al] Chemical compound O.O.O.[Al] MXRIRQGCELJRSN-UHFFFAOYSA-N 0.000 description 1
- DKXNBNKWCZZMJT-UHFFFAOYSA-N O4-alpha-D-Mannopyranosyl-D-mannose Natural products O=CC(O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O DKXNBNKWCZZMJT-UHFFFAOYSA-N 0.000 description 1
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 description 1
- DJNTZVRUYMHBTD-UHFFFAOYSA-N Octyl octanoate Chemical compound CCCCCCCCOC(=O)CCCCCCC DJNTZVRUYMHBTD-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 235000011925 Passiflora alata Nutrition 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 235000011922 Passiflora incarnata Nutrition 0.000 description 1
- 240000002690 Passiflora mixta Species 0.000 description 1
- 235000013750 Passiflora mixta Nutrition 0.000 description 1
- 235000013731 Passiflora van volxemii Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920000148 Polycarbophil calcium Polymers 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Chemical group 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000508269 Psidium Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- JVWLUVNSQYXYBE-UHFFFAOYSA-N Ribitol Natural products OCC(C)C(O)C(O)CO JVWLUVNSQYXYBE-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- OVVGHDNPYGTYIT-VHBGUFLRSA-N Robinobiose Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O1 OVVGHDNPYGTYIT-VHBGUFLRSA-N 0.000 description 1
- 235000017848 Rubus fruticosus Nutrition 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 description 1
- 235000018735 Sambucus canadensis Nutrition 0.000 description 1
- 244000151637 Sambucus canadensis Species 0.000 description 1
- HAIWUXASLYEWLM-AZEWMMITSA-N Sedoheptulose Natural products OC[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@](O)(CO)O1 HAIWUXASLYEWLM-AZEWMMITSA-N 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 240000003829 Sorghum propinquum Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- FHNINJWBTRXEBC-UHFFFAOYSA-N Sudan III Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC(C=C1)=CC=C1N=NC1=CC=CC=C1 FHNINJWBTRXEBC-UHFFFAOYSA-N 0.000 description 1
- 238000003854 Surface Print Methods 0.000 description 1
- 244000145580 Thalia geniculata Species 0.000 description 1
- 235000012419 Thalia geniculata Nutrition 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical class [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 244000291414 Vaccinium oxycoccus Species 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 244000089698 Zanthoxylum simulans Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 108010055615 Zein Proteins 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- UJNOLBSYLSYIBM-NOOOWODRSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2s)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@H](C)O UJNOLBSYLSYIBM-NOOOWODRSA-N 0.000 description 1
- ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2r,3s,4r,5r,6s)-6-[[(1r,3s,4r,5r,8s)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1r,3r,4r,5r,8s)-8-[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- WOHVONCNVLIHKY-UHFFFAOYSA-L [Ba+2].[O-]Cl=O.[O-]Cl=O Chemical compound [Ba+2].[O-]Cl=O.[O-]Cl=O WOHVONCNVLIHKY-UHFFFAOYSA-L 0.000 description 1
- HEAFLBOWLRRIHV-UHFFFAOYSA-N [Na].[P] Chemical compound [Na].[P] HEAFLBOWLRRIHV-UHFFFAOYSA-N 0.000 description 1
- 235000003650 acai Nutrition 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229940091181 aconitic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 150000001299 aldehydes Chemical group 0.000 description 1
- 235000019409 alitame Nutrition 0.000 description 1
- 108010009985 alitame Proteins 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 229920013820 alkyl cellulose Polymers 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- BXOCHUWSGYYSFW-UHFFFAOYSA-N all-trans spilanthol Natural products CC=CC=CCCC=CC(=O)NCC(C)C BXOCHUWSGYYSFW-UHFFFAOYSA-N 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 235000010407 ammonium alginate Nutrition 0.000 description 1
- 239000000728 ammonium alginate Substances 0.000 description 1
- KPGABFJTMYCRHJ-YZOKENDUSA-N ammonium alginate Chemical compound [NH4+].[NH4+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O KPGABFJTMYCRHJ-YZOKENDUSA-N 0.000 description 1
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 1
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000002272 anti-calculus Effects 0.000 description 1
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 239000007961 artificial flavoring substance Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- ZJRXSAYFZMGQFP-UHFFFAOYSA-N barium peroxide Chemical compound [Ba+2].[O-][O-] ZJRXSAYFZMGQFP-UHFFFAOYSA-N 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- YYMVPVZYUYQSJE-UHFFFAOYSA-N benzyl-[2-(2,6-dimethylanilino)-2-oxoethyl]-diethylazanium;benzoate;hydrate Chemical compound O.[O-]C(=O)C1=CC=CC=C1.C=1C=CC=CC=1C[N+](CC)(CC)CC(=O)NC1=C(C)C=CC=C1C YYMVPVZYUYQSJE-UHFFFAOYSA-N 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical class C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 1
- 235000021029 blackberry Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 235000007123 blue elder Nutrition 0.000 description 1
- ODWXUNBKCRECNW-UHFFFAOYSA-M bromocopper(1+) Chemical compound Br[Cu+] ODWXUNBKCRECNW-UHFFFAOYSA-M 0.000 description 1
- 235000010634 bubble gum Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 1
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229940043430 calcium compound Drugs 0.000 description 1
- 150000001674 calcium compounds Chemical class 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 description 1
- 235000019402 calcium peroxide Nutrition 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- QXIKMJLSPJFYOI-UHFFFAOYSA-L calcium;dichlorite Chemical compound [Ca+2].[O-]Cl=O.[O-]Cl=O QXIKMJLSPJFYOI-UHFFFAOYSA-L 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 229940078916 carbamide peroxide Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229940075509 carbomer 1342 Drugs 0.000 description 1
- 229940049638 carbomer homopolymer type c Drugs 0.000 description 1
- 229940082484 carbomer-934 Drugs 0.000 description 1
- 229940043234 carbomer-940 Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 125000004181 carboxyalkyl group Chemical group 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-O carboxymethyl-[3-(dodecanoylamino)propyl]-dimethylazanium Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)=O MRUAUOIMASANKQ-UHFFFAOYSA-O 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 206010061592 cardiac fibrillation Diseases 0.000 description 1
- 239000004075 cariostatic agent Substances 0.000 description 1
- 108010019954 casein phosphopeptide-amorphous calcium phosphate nanocomplex Proteins 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 229960004830 cetylpyridinium Drugs 0.000 description 1
- NEUSVAOJNUQRTM-UHFFFAOYSA-N cetylpyridinium Chemical compound CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NEUSVAOJNUQRTM-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 description 1
- HNEGQIOMVPPMNR-IHWYPQMZSA-N citraconic acid Chemical compound OC(=O)C(/C)=C\C(O)=O HNEGQIOMVPPMNR-IHWYPQMZSA-N 0.000 description 1
- 229940018557 citraconic acid Drugs 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 229940080421 coco glucoside Drugs 0.000 description 1
- 229940048300 coco-caprylate Drugs 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 229940116318 copper carbonate Drugs 0.000 description 1
- 150000001880 copper compounds Chemical class 0.000 description 1
- 229940108925 copper gluconate Drugs 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- GEZOTWYUIKXWOA-UHFFFAOYSA-L copper;carbonate Chemical compound [Cu+2].[O-]C([O-])=O GEZOTWYUIKXWOA-UHFFFAOYSA-L 0.000 description 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000011959 crème brûlée Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229940109275 cyclamate Drugs 0.000 description 1
- 235000019221 dark chocolate Nutrition 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229940073499 decyl glucoside Drugs 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 229960001610 denatonium benzoate Drugs 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- PNOXNTGLSKTMQO-UHFFFAOYSA-L diacetyloxytin Chemical compound CC(=O)O[Sn]OC(C)=O PNOXNTGLSKTMQO-UHFFFAOYSA-L 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- FWBOFUGDKHMVPI-UHFFFAOYSA-K dicopper;2-oxidopropane-1,2,3-tricarboxylate Chemical compound [Cu+2].[Cu+2].[O-]C(=O)CC([O-])(C([O-])=O)CC([O-])=O FWBOFUGDKHMVPI-UHFFFAOYSA-K 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- LRCFXGAMWKDGLA-UHFFFAOYSA-N dioxosilane;hydrate Chemical compound O.O=[Si]=O LRCFXGAMWKDGLA-UHFFFAOYSA-N 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical class C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- IRXRGVFLQOSHOH-UHFFFAOYSA-L dipotassium;oxalate Chemical compound [K+].[K+].[O-]C(=O)C([O-])=O IRXRGVFLQOSHOH-UHFFFAOYSA-L 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- LQJVOKWHGUAUHK-UHFFFAOYSA-L disodium 5-amino-4-hydroxy-3-phenyldiazenylnaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].OC1=C2C(N)=CC(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=C1N=NC1=CC=CC=C1 LQJVOKWHGUAUHK-UHFFFAOYSA-L 0.000 description 1
- FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 description 1
- HSXUHWZMNJHFRV-UHFFFAOYSA-L disodium;6-oxido-5-phenyldiazenyl-4-sulfonaphthalene-2-sulfonate Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C2=C1N=NC1=CC=CC=C1 HSXUHWZMNJHFRV-UHFFFAOYSA-L 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- TVACALAUIQMRDF-UHFFFAOYSA-N dodecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCOP(O)(O)=O TVACALAUIQMRDF-UHFFFAOYSA-N 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000007124 elderberry Nutrition 0.000 description 1
- 239000008393 encapsulating agent Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- UQPHVQVXLPRNCX-UHFFFAOYSA-N erythrulose Chemical compound OCC(O)C(=O)CO UQPHVQVXLPRNCX-UHFFFAOYSA-N 0.000 description 1
- 235000015114 espresso Nutrition 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 229940073505 ethyl vanillin Drugs 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000002600 fibrillogenic effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229910052587 fluorapatite Inorganic materials 0.000 description 1
- 229940077441 fluorapatite Drugs 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- FDTUVFSBEYKVAP-UHFFFAOYSA-N formic acid;pyridine Chemical compound OC=O.C1=CC=NC=C1 FDTUVFSBEYKVAP-UHFFFAOYSA-N 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000019990 fruit wine Nutrition 0.000 description 1
- 229910021485 fumed silica Inorganic materials 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 229940074046 glyceryl laurate Drugs 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 150000002386 heptoses Chemical class 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- LHFKHAVGGJJQFF-JRNWQWJGSA-N hydroxy-α-sanshool Chemical compound C\C=C/C=C/C=C\CC\C=C\C(\O)=N\CC(C)(C)O LHFKHAVGGJJQFF-JRNWQWJGSA-N 0.000 description 1
- BDAGIHXWWSANSR-NJFSPNSNSA-N hydroxyformaldehyde Chemical compound O[14CH]=O BDAGIHXWWSANSR-NJFSPNSNSA-N 0.000 description 1
- LHFKHAVGGJJQFF-UHFFFAOYSA-N hydroxyl-alpha-sanshool Natural products CC=CC=CC=CCCC=CC(=O)NCC(C)(C)O LHFKHAVGGJJQFF-UHFFFAOYSA-N 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 150000002454 idoses Chemical class 0.000 description 1
- 238000001095 inductively coupled plasma mass spectrometry Methods 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical class OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- PZDOWFGHCNHPQD-OQPGPFOOSA-N kojibiose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PZDOWFGHCNHPQD-OQPGPFOOSA-N 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 229960000511 lactulose Drugs 0.000 description 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
- QIGJYVCQYDKYDW-LCOYTZNXSA-N laminarabiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1O QIGJYVCQYDKYDW-LCOYTZNXSA-N 0.000 description 1
- 229940075468 lauramidopropyl betaine Drugs 0.000 description 1
- 229940062711 laureth-9 Drugs 0.000 description 1
- 229940071145 lauroyl sarcosinate Drugs 0.000 description 1
- 229940094506 lauryl betaine Drugs 0.000 description 1
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 1
- 229940048848 lauryl glucoside Drugs 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- KAGBQTDQNWOCND-UHFFFAOYSA-M lithium;chlorite Chemical compound [Li+].[O-]Cl=O KAGBQTDQNWOCND-UHFFFAOYSA-M 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- NWAPVVCSZCCZCU-UHFFFAOYSA-L magnesium;dichlorite Chemical compound [Mg+2].[O-]Cl=O.[O-]Cl=O NWAPVVCSZCCZCU-UHFFFAOYSA-L 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 150000004701 malic acid derivatives Chemical class 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 229940043353 maltol Drugs 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002074 melt spinning Methods 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- HNEGQIOMVPPMNR-NSCUHMNNSA-N mesaconic acid Chemical compound OC(=O)C(/C)=C/C(O)=O HNEGQIOMVPPMNR-NSCUHMNNSA-N 0.000 description 1
- 125000005341 metaphosphate group Chemical group 0.000 description 1
- 229940117845 methacrylic acid - methyl methacrylate copolymer (1:1) Drugs 0.000 description 1
- 229940117837 methacrylic acid - methyl methacrylate copolymer (1:2) Drugs 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- HNEGQIOMVPPMNR-UHFFFAOYSA-N methylfumaric acid Natural products OC(=O)C(C)=CC(O)=O HNEGQIOMVPPMNR-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 102000035118 modified proteins Human genes 0.000 description 1
- 108091005573 modified proteins Proteins 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 150000002763 monocarboxylic acids Chemical group 0.000 description 1
- 235000019960 monoglycerides of fatty acid Nutrition 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 229940070782 myristoyl sarcosinate Drugs 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- OMJWPBNIKBHGQG-UHFFFAOYSA-N n-(4-ethoxyphenyl)-5-methyl-2-propan-2-ylcyclohexane-1-carboxamide Chemical compound C1=CC(OCC)=CC=C1NC(=O)C1C(C(C)C)CCC(C)C1 OMJWPBNIKBHGQG-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- ZVKDZYPEJXGLJG-UHFFFAOYSA-N n-tert-butyl-5-methyl-2-propan-2-ylcyclohexane-1-carboxamide Chemical compound CC(C)C1CCC(C)CC1C(=O)NC(C)(C)C ZVKDZYPEJXGLJG-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- ZYTMANIQRDEHIO-UHFFFAOYSA-N neo-Isopulegol Natural products CC1CCC(C(C)=C)C(O)C1 ZYTMANIQRDEHIO-UHFFFAOYSA-N 0.000 description 1
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 1
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 1
- 235000010434 neohesperidine DC Nutrition 0.000 description 1
- 235000019412 neotame Nutrition 0.000 description 1
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 description 1
- 108010070257 neotame Proteins 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- YZUUTMGDONTGTN-UHFFFAOYSA-N nonaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCO YZUUTMGDONTGTN-UHFFFAOYSA-N 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- HRPZGPXWSVHWPB-UHFFFAOYSA-N octyl decanoate Chemical compound CCCCCCCCCC(=O)OCCCCCCCC HRPZGPXWSVHWPB-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- MPQXHAGKBWFSNV-UHFFFAOYSA-N oxidophosphanium Chemical group [PH3]=O MPQXHAGKBWFSNV-UHFFFAOYSA-N 0.000 description 1
- LMXFTMYMHGYJEI-UHFFFAOYSA-N p-menthane-3,8-diol Chemical compound CC1CCC(C(C)(C)O)C(O)C1 LMXFTMYMHGYJEI-UHFFFAOYSA-N 0.000 description 1
- 229930006948 p-menthane-3,8-diol Natural products 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 235000021400 peanut butter Nutrition 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- MAGQQZHFHJDIRE-BNFZFUHLSA-N pellitorine Chemical compound CCCCC\C=C\C=C\C(=O)NCC(C)C MAGQQZHFHJDIRE-BNFZFUHLSA-N 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 229940038597 peroxide anti-acne preparations for topical use Drugs 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 125000000864 peroxy group Chemical group O(O*)* 0.000 description 1
- JRKICGRDRMAZLK-UHFFFAOYSA-L persulfate group Chemical group S(=O)(=O)([O-])OOS(=O)(=O)[O-] JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- GVKCHTBDSMQENH-UHFFFAOYSA-L phloxine B Chemical compound [Na+].[Na+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 GVKCHTBDSMQENH-UHFFFAOYSA-L 0.000 description 1
- ZYIBVBKZZZDFOY-UHFFFAOYSA-N phloxine O Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(Br)=C(O)C(Br)=C1OC1=C(Br)C(O)=C(Br)C=C21 ZYIBVBKZZZDFOY-UHFFFAOYSA-N 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
- 229960001416 pilocarpine Drugs 0.000 description 1
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 description 1
- 229940075559 piperine Drugs 0.000 description 1
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 description 1
- 235000019100 piperine Nutrition 0.000 description 1
- ONJQDTZCDSESIW-UHFFFAOYSA-N polidocanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO ONJQDTZCDSESIW-UHFFFAOYSA-N 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229950005134 polycarbophil Drugs 0.000 description 1
- 229920000570 polyether Chemical group 0.000 description 1
- 229940048845 polyglyceryl-3 diisostearate Drugs 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920000137 polyphosphoric acid Chemical class 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 150000007519 polyprotic acids Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 235000010408 potassium alginate Nutrition 0.000 description 1
- 239000000737 potassium alginate Substances 0.000 description 1
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- UIQAPZITHGDLJP-UHFFFAOYSA-L potassium sodium 2-hydroxy-2-oxoacetate Chemical compound C(C(=O)[O-])(=O)[O-].[Na+].C(C(=O)O)(=O)O.[K+] UIQAPZITHGDLJP-UHFFFAOYSA-L 0.000 description 1
- VISKNDGJUCDNMS-UHFFFAOYSA-M potassium;chlorite Chemical compound [K+].[O-]Cl=O VISKNDGJUCDNMS-UHFFFAOYSA-M 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- 239000012716 precipitator Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- TVRGPOFMYCMNRB-UHFFFAOYSA-N quinizarine green ss Chemical compound C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1 TVRGPOFMYCMNRB-UHFFFAOYSA-N 0.000 description 1
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- HEBKCHPVOIAQTA-ZXFHETKHSA-N ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- OVVGHDNPYGTYIT-BNXXONSGSA-N rutinose Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 OVVGHDNPYGTYIT-BNXXONSGSA-N 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- HSNZZMHEPUFJNZ-SHUUEZRQSA-N sedoheptulose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO HSNZZMHEPUFJNZ-SHUUEZRQSA-N 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229960004249 sodium acetate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 1
- 229960002218 sodium chlorite Drugs 0.000 description 1
- 229940080272 sodium coco-sulfate Drugs 0.000 description 1
- 229940079781 sodium cocoyl glutamate Drugs 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229940048106 sodium lauroyl isethionate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 1
- 229940075560 sodium lauryl sulfoacetate Drugs 0.000 description 1
- PFUVRDFDKPNGAV-UHFFFAOYSA-N sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 description 1
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- ILJOYZVVZZFIKA-UHFFFAOYSA-M sodium;1,1-dioxo-1,2-benzothiazol-3-olate;hydrate Chemical compound O.[Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 ILJOYZVVZZFIKA-UHFFFAOYSA-M 0.000 description 1
- BRMSVEGRHOZCAM-UHFFFAOYSA-M sodium;2-dodecanoyloxyethanesulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)OCCS([O-])(=O)=O BRMSVEGRHOZCAM-UHFFFAOYSA-M 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 229940071440 soy protein isolate Drugs 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 229940013123 stannous chloride Drugs 0.000 description 1
- RCIVOBGSMSSVTR-UHFFFAOYSA-L stannous sulfate Chemical compound [SnH2+2].[O-]S([O-])(=O)=O RCIVOBGSMSSVTR-UHFFFAOYSA-L 0.000 description 1
- 229940007163 stannous tartrate Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 229910000018 strontium carbonate Inorganic materials 0.000 description 1
- 229940086735 succinate Drugs 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 230000019635 sulfation Effects 0.000 description 1
- 238000005670 sulfation reaction Methods 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- IUTCEZPPWBHGIX-UHFFFAOYSA-N tin(2+) Chemical compound [Sn+2] IUTCEZPPWBHGIX-UHFFFAOYSA-N 0.000 description 1
- FSBZGYYPMXSIEE-UHFFFAOYSA-H tin(2+);diphosphate Chemical compound [Sn+2].[Sn+2].[Sn+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O FSBZGYYPMXSIEE-UHFFFAOYSA-H 0.000 description 1
- 229910000375 tin(II) sulfate Inorganic materials 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- GTZCVFVGUGFEME-UHFFFAOYSA-N trans-aconitic acid Natural products OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 150000003628 tricarboxylic acids Chemical class 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 229940072029 trilaureth-4 phosphate Drugs 0.000 description 1
- 150000003641 trioses Chemical class 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 238000001238 wet grinding Methods 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 235000020334 white tea Nutrition 0.000 description 1
- 235000019220 whole milk chocolate Nutrition 0.000 description 1
- 239000010456 wollastonite Substances 0.000 description 1
- 229910052882 wollastonite Inorganic materials 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
- 229940071566 zinc glycinate Drugs 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- LRXTYHSAJDENHV-UHFFFAOYSA-H zinc phosphate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LRXTYHSAJDENHV-UHFFFAOYSA-H 0.000 description 1
- 229910000165 zinc phosphate Inorganic materials 0.000 description 1
- 229940077935 zinc phosphate Drugs 0.000 description 1
- UJNPHNKJSKIVTE-SCGRZTRASA-L zinc;(2s)-2-amino-5-(diaminomethylideneamino)pentanoate Chemical compound [Zn+2].[O-]C(=O)[C@@H](N)CCCNC(N)=N.[O-]C(=O)[C@@H](N)CCCNC(N)=N UJNPHNKJSKIVTE-SCGRZTRASA-L 0.000 description 1
- UOXSXMSTSYWNMH-UHFFFAOYSA-L zinc;2-aminoacetate Chemical compound [Zn+2].NCC([O-])=O.NCC([O-])=O UOXSXMSTSYWNMH-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8129—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers or esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers, e.g. polyvinylmethylether
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0204—Specific forms not provided for by any of groups A61K8/0208 - A61K8/14
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0245—Specific shapes or structures not provided for by any of the groups of A61K8/0241
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/027—Fibers; Fibrils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A46—BRUSHWARE
- A46B—BRUSHES
- A46B2200/00—Brushes characterized by their functions, uses or applications
- A46B2200/10—For human or animal care
- A46B2200/1066—Toothbrush for cleaning the teeth or dentures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
- A61K2800/882—Mixing prior to application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/95—Involves in-situ formation or cross-linking of polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Geometry (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
本发明涉及具有氟离子源的口腔护理组合物和/或单位剂量口腔护理组合物;具有高平均氟离子摄取的口腔护理组合物和/或单位剂量口腔护理组合物;具有一种或多种纤维网形成材料、钙离子源和氟离子源并且具有高平均氟摄取的口腔护理组合物。
Description
技术领域
本发明涉及包含氟离子源的口腔护理组合物。本发明还涉及包含氟离子源的单位剂量口腔护理组合物。本发明还涉及具有高平均氟离子摄取的口腔护理组合物和/或单位剂量口腔护理组合物。
背景技术
洁齿剂组合物通常被配制成可从管中挤出的糊剂。洁齿剂组合物可包含金属离子、氟离子、磨料、钙源、表面活性剂、增白剂、湿润剂、增稠剂和其他制剂成分。通常,必须仔细配制洁齿剂组合物,以避免在管中的反应性,但是要保持其在口腔中的反应性。在许多情况下,必须取代或除去成分以平衡管中的反应性与口腔中的有益效果。
具体地讲,可将氟离子源诸如氟化钠、氟化亚锡和/或单氟磷酸钠等加入到洁齿剂组合物中,以递送抗龋齿有益效果。然而,由于氟离子和其它洁齿剂组分诸如钙离子之间的反应性,故氟离子源可能难以掺入到洁齿剂和/或口腔护理组合物中。
通过使氟离子摄取到釉质中,氟离子提供抗龋齿有益效果。氟与牙齿矿物质组分(称为羟基磷灰石或HAP)的相互作用通过HAP中的OH-被F-取代而产生氟代羟基磷灰石(FAP)矿物质。氟作为FAP掺入到牙釉质中导致氢键合增加、晶格更致密、以及牙釉质溶解度的总体降低。氟向羟基磷灰石(HAP)晶格中的掺入可在牙齿形成时发生或者在其已长出之后通过离子交换发生。此外,釉质溶解度随着氟掺入量的增加而降低。因此,氟常规加入到洁齿剂和漱口液中以强化牙齿的牙釉质。
遗憾的是,氟生物利用率可能由于以下原因而显著改变:(i)氟离子与其它组分诸如钙离子、磨料体系、螯合剂和增白剂之间的化学反应性,(ii)水解,以及(iii)氧化。因此,根据其它反应性组分的浓度和存在,糊剂中氟离子的氟生物利用率随时间的变化而受到影响,因为许多氟化合物处于水相中时易于水解和/或氧化。
因此,仅通过在储存期间使氟离子与其它洁齿剂组分之间的相互作用最小化,以使与口腔表面诸如釉质、牙质、牙龈、牙斑和细菌的反应性的氟离子可用性最大化,才可能将氟离子掺入到洁齿剂组合物中。因此,需要使氟离子源与其它洁齿剂组分之间的反应性最小化的口腔护理组合物。
发明内容
本文公开了一种单位剂量口腔护理组合物,所述单位剂量口腔护理组合物包含:(a)由一种或多种纤维网形成材料形成的纤维组合物;(b)氟离子源;以及(c)磨料。
本文公开了一种口腔护理组合物,所述口腔护理组合物包含:(a)一种或多种纤维网形成材料;(b)钙离子源;以及(c)氟离子源,其中所述口腔护理组合物具有至少约1000ppm的平均氟摄取。
本文公开了一种口腔护理组合物,所述口腔护理组合物包含:(a)一个或多个非织造纤维网层,所述一个或多个非织造纤维网层包含:(i)一种或多种纤维网形成材料,以及(ii)氟离子源;以及(b)非纤维组合物,所述非纤维组合物包含钙离子源。
本文公开了一种口腔护理组合物,所述口腔护理组合物包含:(a)一个或多个非织造纤维网层,所述一个或多个非织造纤维网层包含:(i)一种或多种纤维网形成材料,以及(ii)钙离子源;以及(b)非纤维组合物,所述非纤维组合物包含氟离子源。
本文公开了一种口腔护理组合物,所述口腔护理组合物包含:(a)一个或多个非织造纤维网层,所述一个或多个非织造纤维网层包含(i)一种或多种纤维网形成材料,以及(ii)金属离子源,所述金属离子源包括亚锡离子源、锌离子源、或它们的组合;以及(b)非纤维组合物,所述非纤维组合物包含磨料。
本文公开了一种口腔护理组合物,所述口腔护理组合物包含:(a)一个或多个非织造纤维网层,所述一个或多个非织造纤维网层包含(i)一种或多种纤维网形成材料,以及(ii)磨料;(b)非纤维组合物,所述非纤维组合物包含金属离子源,所述金属离子源包括亚锡离子源、锌离子源、或它们的组合。
具体实施方式
本发明涉及包含氟离子源的口腔护理组合物。本发明还涉及包含氟离子源的单位剂量口腔护理组合物。本发明还涉及具有高平均氟离子摄取的口腔护理组合物和/或单位剂量口腔护理组合物。
由于氟离子源与口腔护理组合物中其它成分的反应性和/或含水口腔护理组合物中氟离子源的氧化或水解,故氟离子源可能难以在口腔护理组合物中配制。
本发明涉及口腔护理组合物,其使用组合设计以在物理上将氟离子与该口腔护理组合物的其它反应性组分分离。例如,氟离子可处于口腔护理组合物的一个位置,并且钙离子源或钙磨料可处于口腔护理组合物的单独位置。虽然洁齿剂反应性通常通过制剂设计来操纵,但是使用非织造纤维网将允许通过将组分置于固相中(其中反应性较低)来使之分离或通过口腔护理组合物的组合物设计来在物理上分离成分,从而显著降低洁齿剂反应性。
定义
为了更清楚地定义本文所用的术语,提供了以下定义。除非另外指明,以下定义均适用于本公开。如果在本公开中使用术语但未在本文中具体定义,则可应用来自IUPACCompendium of Chemical Terminology第2版(1997)的定义,只要该定义不与本文应用的任何其他公开或定义相冲突,或者不使应用该定义的任何权利要求不确定或不能实现。
如本文所用,术语“口腔护理组合物”是指如下的产品:该产品在通常的使用过程中在口腔中保留足够长的时间以接触牙齿表面和/或口腔组织中的一些或全部以用于口腔健康的目的。在一个实施方案中,组合物保留在口腔中以递送口腔护理活性剂。本发明的口腔组合物可为各种形式,包括牙膏、洁齿剂、牙胶、牙粉、片剂、漱口液、龈下凝胶、泡沫、摩丝、口香糖、唇膏、海绵、牙线、抛光糊剂、凡士林凝胶、义齿产品、非织造纤维网或泡沫。在一个实施方案中,口腔组合物为非织造纤维网的形式。在另一个实施方案中,口腔组合物为洁齿剂的形式。还可将口腔组合物掺入到条或膜上,以用于直接施用或粘附到口腔表面或掺入到牙线中。该口腔护理组合物还可为可直接施用到口腔表面的条。该条在与水分接触或刷牙时可至少部分地溶解。
如本文所用,术语“口服用载体”是指合适的媒介物和成分,其可用于形成本发明的组合物和/或以安全有效的方式将本发明的组合物施用于口腔中。
如本文所用,术语“有效量”是指化合物或组合物的量足以引起积极的有益效果,口腔健康有益效果,和/或足够低的量以避免严重的副作用,即在技术人员的合理判断范围内提供合理的效险比。根据口腔健康有益效果的类型和活性化合物的功效,“有效量”是指按该组合物的重量计至少约0.0001%的材料,0.001%的材料或0.01%的材料。
如本文所用,除非另外指明,否则术语“洁齿剂”是指用于清洁、治疗或接触口腔表面的糊剂、凝胶、粉末、片剂或液体制剂。另外,如本文所公开,洁齿剂是指用于清洁口腔表面的非织造纤维网。如本文所用,术语“牙齿”是指自然牙齿以及人造牙齿或假牙。
如本文所用,术语“长丝”是指可用于形成本发明类型的非织造纤维网的薄的柔性线状物体。长丝的长度可大大超过其直径,即长度与直径的比率为至少约5、10或25。
本发明的长丝可经由合适的纺丝操作,诸如熔喷或纺粘,由非织造纤网形成材料纺制而成。
通常认为长丝实质上是连续的或基本上连续的。长丝相对地比纤维长。长丝的非限制性示例可包括熔喷长丝、纺粘长丝以及它们的组合。在一个实施方案中,长丝为熔喷长丝。
在一个示例中,长丝可为纤维的形式,诸如当长丝被切割成较短长度时。因此,在一个示例中,本发明还包括包含本发明长丝的组合物的纤维。
如本文所用,“非织造纤维网形成材料”是指适用于诸如通过熔喷、纺粘或流体膜原纤化来制备长丝的组合物。非织造纤维网形成材料包括一种或多种非织造纤维网形成材料,其表现出使得这些材料适于纺丝成长丝的特性。
如本文所用,关于长丝的“长度”是指沿长丝的最长轴从一端至另一端的长度。如果长丝在其中具有打结、卷曲或弯曲,那么长度为沿长丝的完整线路的长度。
如本文所用,关于长丝的“平均直径”根据本文所述的直径测试方法测量。
如本文所用,术语“能够崩解的”和“崩解”是指口腔护理组合物、长丝,或非织造材料在暴露于预期用途条件时减少成组分、片段或组合物。
如本文所用,术语“溶解”是指使口腔护理组合物、长丝或非织造纤维网大部分或完全增溶。口腔护理组合物可看起来是明显溶解的,即使一些组分不完全溶解,例如交联的聚丙烯酸聚合物形成澄清的凝胶,提供溶解的外观,同时不受理论的束缚,该澄清的凝胶简单水合。另一个示例是磨料,其即使可构成组合物的大部分,但是根本不溶解。如果仅磨料尚未溶解,则包含该磨料的口腔组合物仍将被认为是“溶解的”。当任何剩余的颗粒具有2mm或更小的直径时,口腔护理组合物完全溶解。
如本文所用,术语“施用”包括喷涂、撒粉、喷淋、涂覆、表面印刷(例如,以所需装饰、装饰品或图案的形状)、浇注、注射到内部、浸渍或通过任何其他合适的方式,诸如通过使用沉积器、筛或粉末床。
如本文所用,“预期用途条件”是指当口腔护理组合物用于其设计目的时,包含一根或多根本发明长丝的口腔护理组合物暴露于其下的温度、物理、化学和/或机械条件。本发明的口腔护理组合物可经由口腔、口、咽喉以及它们的组合施用于哺乳动物。预期用途条件可以是哺乳动物的口腔、口和/或咽喉中的温度、物理、化学和/或机械条件。
如本文所用,“触发条件”是指用作刺激并引发或促成长丝变化的任何行为或事件,诸如丧失或改变长丝的物理结构和/或释放口腔护理活性物质包括溶解、水合和溶胀。一些触发条件包括合适的pH、温度、剪切速率或水含量。
如本文所用,关于长丝的形态改变的“形态变化”是指长丝发生其物理结构的改变。本发明的长丝的形态变化的非限制性示例包括溶解、熔融、溶胀、皱缩、破裂成片、变长、变短、剥离、分裂、切碎、内爆、扭曲以及它们的组合。当将本发明的长丝暴露于预期用途条件时,其可完全或基本上损失其长丝物理结构或其可具有其形态变化或可保持或基本上保持其长丝物理结构。
如本文所用,“纤维网”是指已通过任何方法形成纤维网并通过任何方法粘结在一起的任何性质或来源的连续长丝或纤维的片材。
如本文所用并由欧洲一次性用品和非织造织物协会(EDANA)定义的“非织造纤维网”是指通过任何方式形成纤维网,并通过任何方式粘合在一起的任何性质或来源的连续长丝或纤维片,但织造或针织除外。通过湿磨法获得的毛毡不是非织造织物。在一个示例中,根据本发明的非织造纤维网是指长丝在结构内的有序排列以便执行功能。在一个示例中,本发明的非织造纤维网是包括多根两根或更多根和/或三根或更多根长丝的排列,这些长丝相互缠结或以其他方式与彼此相关联以形成非织造纤维网。
术语RDA是指FDI-ISO 11609中定义的相对牙本质磨蚀性放射性牙本质磨蚀性。术语PCR是指表膜清洁率(Pellicle Cleaning Ratio),其如由Stookey等人(1982)在原始论文中定义以及后来由Schemehorn等人(2011)使用,以表征口腔护理组合物从釉质片上去除实验室来源的人样色斑的相对效力。这些实验技术将在下文中更详细地描述。
除非另外指明,否则下文中所用的所有百分比和比率均按总组合物的重量计。除非另外指明,否则本文提及的所有成分的百分比、比率和水平均基于该成分的实际量,并且不包括在可商购获得的产品中可与这些成分一起使用的溶剂、填料或其它物质。除非另外指明,否则本文所涉及的所有测量均在25℃下进行。
本发明的组合物、工艺和方法可包括、由或基本上由本文所述的本发明的基本要素和限制,以及本文所述或可用于旨在供哺乳动物使用或消费,优选地供人类使用的口腔护理组合物中的任何附加或可选成分、组分或限制。
单位剂量口腔护理组合物
本发明的口腔护理组合物可为单位剂量口腔护理组合物。单位剂量口腔护理组合物是将在单次使用中施用给患者或消费者的口腔护理组合物的量。单位剂量口腔护理组合物可为单位剂量洁齿剂、单位剂量漱口液、单位剂量牙胶、单位剂量牙齿美白组合物,或任何其他合适的单位剂量口腔护理组合物,这些单位剂量口腔护理组合物能够在口腔中保留足够长的时间以接触牙齿表面和/或口腔组织中的一些或全部以用于口腔健康的目的。
单位剂量口腔护理组合物的量(以质量和/或体积计)基于单位剂量口腔护理组合物的所需类型来确定。例如,单位剂量洁齿剂的尺寸可被设定成根据当地法律和法规诸如美国食品药品监督管理局(FDA)专著在单次使用中递送正确量的氟,这允许包含850ppm至1150ppm和/或1500ppm的氟离子的制剂。另外,单位剂量洁齿剂的尺寸可被设定成递送正确量或比率的其他成分,诸如抗微生物剂、磨料、表面活性剂、风味剂、金属离子等。类似地,单位剂量漱口液的尺寸可设定成递送正确量的漱口液成分,诸如氟离子、抗微生物剂、磨料、表面活性剂、风味剂、金属离子等。
单位剂量口腔护理组合物可为小袋、小滴、固体开孔泡沫、固体闭孔泡沫、纤维组合物、糊剂组合物、凝胶组合物、片剂组合物、条状组合物、带状组合物和/或本段所述一种或多种形式的组合物的形式。
单位剂量口腔护理组合物的尺寸可被设定成配合手动牙刷、电动牙刷,或设计成有助于使单位剂量口腔护理组合物接触口腔表面(包括但不限于牙齿)的任何其他施用装置。
本发明的单位剂量口腔护理组合物可以是垫、条、带或片剂形式的基本上平的或平的组合物,其具有约0.05毫米(mm)至约20mm,约0.05mm至约10mm,约0.05mm至约5mm,约0.5mm至约1mm,约0.05mm至约0.5mm,约0.05mm至约0.25mm或约0.05mm至约0.1mm,如通过下文所述的厚度方法所测量的。单位剂量口腔护理组合物可成型为具有约0.5厘米(cm)至约10cm,约1cm至约5cm,或约1.5cm至约3cm长度的圆柱形(例如,通过轧制)。单位剂量口腔护理组合物可以是包括立方体的矩形棱柱,其中矩形棱柱的最长边具有约5mm至20mm,约10mm至15mm或约5mm至约10mm的长度,如通过本文所述的厚度方法所测量的。如果剂量的尺寸改变,则该剂量的基重可改变。单位剂量口腔护理组合物可为圆形或椭圆形,其中圆形的直径或椭圆形的最长部分的长度为约5mm至约5cm,5mm至约100mm,5mm至约50mm,1cm至约5cm或100mm至约1cm。
单位剂量口腔护理组合物可为一个或多个平片或垫的形式,该一个或多个平片或垫具有足够的尺寸以能够由使用者容易地处理。单位剂量口腔护理组合物可包含一种单位剂量的一种或多种口腔护理活性物质,该一种或多种口腔护理活性物质可提供一种或多种口腔护理有益效果并且/或者治疗一种或多种口腔护理病症。单位剂量口腔护理组合物可具有正方形、矩形、椭圆形、圆形、盘形或任何其他合适的形状。单位剂量口腔护理组合物还可为连续条的形式,包括在带状辊分配器上递送,该辊分配器具有经由穿孔和/或切割机构分配的单独部分。
单位剂量口腔护理组合物可允许该剂量在相同组合物内包含不相容的组分。如果当组分在相同溶液中或作为非固体混合物时,这些组分中的至少一种组分在功效、稳定性或生物利用率方面具有显著的降低,则认为这些组分彼此不相容。不相容的组分可以是彼此化学相互作用以形成新化合物、络合物和/或盐的组分和/或将分离成组合物的离散部分或相以使不利相互作用最小化的组分。
不相容组分的示例可包括但不限于金属离子源和二氧化硅磨料、金属离子源和多磷酸盐、金属离子源和焦磷酸盐、钙离子源和氟离子源、钙离子源和磷酸盐、钙离子源和焦磷酸盐、草酸根离子和过氧化合物、氟化亚锡和过氧化物化合物、阳离子抗微生物剂(诸如氯化十六烷基吡啶鎓)和氟离子源、酸和碱、钙离子源和螯合剂(诸如EDTA)、氧化剂和还原剂、疏水性组分(诸如凡士林、硅氧烷、聚丁烯)和亲水性组分(诸如水和醇),以及/或者如上文定义的任何其他不相容组分。
如本文所述的单位剂量口腔护理组合物可被设计成通过使成分之间的反应性最小化而使成分的生物利用率、稳定性和/或功效最大化。使成分之间的反应性最小化可通过在物理上将成分分离成组合物的离散部分或通过将一种或多种成分置于反应性较低的固相中来实现。
在小袋组合物的上下文中,内部体积可分成多个离散的、分层的、相邻的和/或叠加的部分,该小袋组合物可在每个部分中放置一种或多种组分。例如,氟离子源可在小袋组合物的一部分中,而钙离子源可在小袋组合物的另一部分中。另外,金属离子源可在小袋组合物的一部分中,而二氧化硅磨料或多磷酸盐可在小袋组合物的另一部分中。
在纤维口腔护理组合物的上下文中,一种或多种反应性组分可在一个非织造纤维网层中,并且一种或多种反应性组分可在另一个非织造纤维网层中。另外,一种或多种反应性组分可存在于一个或多个非织造纤维网层中,并且一种或多种反应性组分可介于该一个或多个非织造纤维网层之间、在该一个或多个非织造纤维网层顶部上、在该一个或多个非织造纤维网层下面、折叠在该一个或多个非织造纤维网层内、与该一个或多个非织造纤维网层相邻,或者与该一个或多个非织造纤维网层重叠,诸如在非纤维组合物中。例如,氟离子源可在包含一个或多个非织造纤维网层的第一纤维组合物内纺丝或与第一纤维组合物混合,并且钙离子源可在包含一个或多个非织造纤维网层的第二纤维组合物内纺丝或与第二纤维组合物混合。可使用任何合适的方式将第一纤维组合物和第二纤维组合物组装成单个多层组合物。另外,氟离子源可在包含一个或多个非织造纤维网层的纤维组合物内纺丝或与该纤维组合物混合,并且钙离子源可作为固体组合物或至少部分溶解于或至少部分分散于液体组合物中而存在于非纤维组合物中。纤维组合物和非纤维组合物可组装成多层组合物,或者非纤维组合物可在纤维组合物之间、之上、之下、与其折叠、相邻或叠加。
在泡沫口腔护理组合物诸如柔性多孔可溶性固体结构的上下文中,反应性组分可在开孔或闭孔泡沫内,或在开孔或闭孔泡沫内混合在一起,该泡沫组合物描述于US 2011/0027328,其以引用方式并入本文。一种或多种反应性组分可存在于泡沫组合物中,而一种或多种反应性组分可存在于涂覆固体泡沫组合物表面的非泡沫组合物中,如表面驻留颗粒涂层。
如本文所述,单位剂量口腔护理组合物的使用允许易于携带和能够更好地控制剂量的能力。例如,由于目前对于航空公司的关于液体产品的限制,乘客限于仅携带少量的漱口液或洁齿剂,或限于将他的漱口液或洁齿剂包装在其检查过的行李中。如果口腔护理组合物为单位剂量的形式,那么乘客可精确地将所需量包装到登机行李中,而无需担心航空公司包装限制。
纤维口腔护理组合物
口腔护理组合物可为纤维口腔护理组合物。纤维口腔护理组合物可包含纤维组合物和/或非纤维组合物。纤维组合物可包含至少一个纤维网。纤维组合物可包含非织造纤维网和/或织造纤维网。
纤维组合物可包含一个或多个纤维网层。该一个或多个纤维网层可包括一根或多根长丝和/或纤维。口腔护理组合物可包含第一纤维网和第二纤维网,其中第一纤维网和第二纤维网包含不同的组分。
纤维组合物可包含任何合适的口腔护理组分。纤维组合物可包含本文所述的任何组分。
纤维网可包含多于一根长丝。纤维网可包含均包含口腔护理活性物质的第一长丝和第二长丝,并且该口腔护理活性物质可为相同的口腔护理活性物质或不同的口腔护理活性物质。纤维网可包含第一长丝和第二长丝,第一长丝包含即时递送口腔护理活性物质,第二长丝包含延长递送、延迟递送和/或定向递送口腔护理活性物质。纤维网可包含第一长丝、第二长丝和第三长丝,其中每根长丝包含不同的口腔护理组分。
从组成的角度来看,纤维网或口腔护理组合物可包含根据本发明的多根相同或基本上相同的长丝。纤维网或口腔护理组合物可包含两种或更多种根据本发明的不同长丝。长丝差异的非限制性示例可为物理差异诸如直径、长度、质地、形状、硬度、弹性等的差异;化学差异诸如交联水平、溶解度、熔点、玻璃化转变温度(Tg)、纤维网形成材料、颜色、口腔护理活性物质的量、纤维网形成材料的量、口腔护理组合物上涂料组合物的存在,口腔护理活性物质的化学组成包括口腔护理活性物质是否是即时递送、延迟递送、延长递送或定向递送等;当长丝暴露于预期用途条件时是否丧失其物理结构的差异;当长丝暴露于预期用途条件时是否改变形态的差异;以及何时和何处经历来自口腔护理活性物质的有益效果的差异。在一个示例中,口腔护理组合物或纤维网内的两种或更多种长丝可包含相同的纤维网形成材料,但是具有不同的口腔护理活性物质。
纤维网可包含两种或更多种长丝,其中这些长丝以不同的速率释放口腔护理活性物质。不同的速率可由定位在纤维网的外表面处的长丝引起。
口腔护理组合物可包含非纤维组合物,按该口腔护理组合物的重量计,该非纤维组合物在重量百分比上可大于或可不大于纤维组合物。非纤维组合物可介于第一纤维网和第二纤维网之间。非纤维组合物的至少一部分可与纤维组合物的表面接触。非纤维组合物可放置在单个纤维网层上,并且纤维网层可在非纤维组合物的顶部上折叠,与非纤维组合物一起轧制,放置在纤维组合物的顶部或下方,以及/或者纤维组合物可包裹纤维组合物。
非纤维组合物可包含任何合适的口腔护理组分。非纤维组合物可包含本文所述的任何组分。非纤维组合物可为液体、固体、含水的和/或它们的组合。
本发明的口腔护理组合物可具有每平方米约10克(g/m2)至约5000g/m2,约25g/m2至约2500g/m2,约40g/m2至约1500g/m2或约500g/m2至约2000g/m2的基重。
纤维口腔护理组合物可包含如本文所述的一般认为不相容的两种或更多种组分或口腔护理活性物质。例如,第一纤维网层可包含氟离子源,并且第二纤维网层可包含钙离子源。在另一个示例中,第一纤维网层可包含金属离子源,诸如亚锡离子源,并且非纤维组合物可包含二氧化硅磨料或多磷酸盐。
口腔护理组合物或纤维网可表现出不同的区域,诸如不同基重、密度和/或厚度的区域。口腔护理组合物或纤维网可包括与纤维网的其他部分不同的长丝的离散区域。
口腔护理组合物或纤维网可包括一种或多种纹理化的、浅凹的或形貌图案化的表面,包括字母、徽标或数字。纹理化口腔护理组合物可起因于长丝或纤维网的形状,因为组合物的最外表面包含相对于表面的其他区域凸起的部分。凸起部分可由口腔护理组合物的成形形状产生,例如纤维网可形成为浅凹状或网格状图案。凸起部分也可为起绉加工、印花涂层、压花图案的结果,或组合物自身的物理形式的结果。
可将本发明的纤维网压成膜以形成口腔护理组合物;这可通过施加压缩力和/或加热纤维网以将纤维网转化成膜来完成。该膜可包含存在于本发明的长丝中的口腔护理活性物质。纤维网可完全转化为膜,或者纤维网的部分可在该纤维网部分转化为膜之后保持膜的形式。口腔护理组合物可构成一个或多个纤维网,其中这些纤维网中的至少一个纤维网已被压成膜。口腔护理组合物可包含已被压成膜的两个或更多个纤维网。
纤维网可被轧制、压缩、切割或堆叠以形成三维口腔护理组合物。例如,可将纤维网压成丸剂或片剂,轧制成圆柱体,或压缩成或堆叠成矩形棱柱以形成口腔护理组合物。
口腔护理组合物可构成一个或多个纤维网层,这些纤维网层任选地经由粘结方法(包括热、湿气、超声、压力等)粘结在一起。口腔护理组合物可构成一个或多个纤维网层,这些纤维网层任选地经由压缩粘结在一起。
口腔护理组合物或非织造纤维网可在一个或多个纤维网层中全部或局部地穿孔有穿入或穿过口腔护理组合物的洞或通道。这些穿孔可作为经由从相邻带、转筒、辊的表面或其他表面延伸的长钉制备纤维网或口腔护理组合物的一部分而形成。另选地,这些穿孔可在形成纤维网或口腔护理组合物后,通过用销钉、针或其他锋利物体戳或刺多孔固体的方法形成。
长丝
口腔护理组合物可包含一根或多根长丝。在一个实施方案中,本发明的长丝表现出大于约0.1英寸,在另选实施方案中大于约0.2英寸,在另一个实施方案中大于约0.3英寸以及在另一个实施方案中大于约2英寸的长度。
长丝可具有小于约150微米(μm),小于约100μm,小于约10μm或小于约1μm的平均直径,其中相对标准差小于100%,小于80%,小于60%或小于50%,诸如在10%至50%的范围内。如本文所述,显著数目是指所有长丝的至少10%,在另一个实施方案中是指所有长丝的至少25%,在另一个实施方案中是指所有长丝的至少50%,在再一个实施方案中是指所有长丝的至少75%。显著数目可以为所有长丝的至少99%。所有长丝的至少50%可具有小于约10μm的平均直径。由本公开的方法生产的长丝可以具有显著数量的平均直径小于约1μm的长丝或亚微米长丝。在一个实施方案中,口腔护理组合物可包含平均直径小于约1μm的所有长丝的至少25%,平均直径小于约1μm的所有长丝的至少35%,平均直径小于约1μm的所有长丝的至少50%或平均直径小于约1μm的所有长丝的至少75%。
长丝可包含按长丝的重量计小于30%的水分,按长丝的重量计小于20%的水分,按长丝的重量计小于约10%的水分,按长丝的重量计小于约5%的水分,按长丝的重量计小于约3%,按长丝的重量计小于约1%或按长丝的重量计小于约0.1%。
本发明的长丝可为单组分和/或多组分。长丝可为双组分长丝。长丝可为三组分长丝。多组分长丝可为任何形式,诸如并列型、芯鞘型、海岛型等。
本发明的长丝可为熔喷长丝。本发明的长丝可为纺粘长丝。在释放一种或多种长丝的活性剂之前和/或之后,这些长丝可为中空长丝。
长丝可包含长丝内的口腔护理活性物质和长丝的外表面上的口腔护理活性物质(诸如长丝上的涂层)。在长丝的外表面上的口腔护理活性物质可与长丝中存在的活性剂相同或不同。如果不同,则口腔护理活性物质可彼此相容或不相容。
固体泡沫组合物
口腔护理组合物可为固体泡沫组合物,诸如US 2011/0027328中所述的柔性多孔溶解固体结构,该专利以引用方式并入本文。固体泡沫组合物可为开孔泡沫或闭孔泡沫的形式。
固体泡沫组合物可包含任何合适的口腔护理组分。固体泡沫组合物可包含本文所述的任何组分。固体泡沫组合物可包含表面驻留涂料组合物。表面驻留涂料组合物可包含任何合适的口腔护理组分或本文所述的任何组分。
重要的是,美国专利申请2011/0027328未公开、教导或提出必须最小化焦磷酸盐的量以便产生固体可溶性泡沫。事实上,美国专利申请2011/0027328仅教导了具有大量焦磷酸盐的示例泡沫组合物。因此,在此出乎意料地发现,焦磷酸盐妨碍泡沫组合物形成过程。
因此,本发明的固体泡沫组合物包含泡沫形成材料、一种或多种表面活性剂、增塑剂,并且其中固体泡沫组合物具有小于约5%,小于约1%的无机金属盐、多磷酸盐或具体地讲焦磷酸盐或不含这些物质。泡沫形成材料是表现出适于制备泡沫的特性的任何合适的材料。泡沫形成材料的非限制性示例可包括由美国专利申请2011/0027328公开的水溶性聚合物。
纤维网形成材料
纤维网可通过任何合适的方式形成。纤维网可包括纺丝纤维和/或纺丝长丝。非织造纤维网可由纤维网形成材料或非织造纤维网形成材料制成,如美国专利申请16/250,455、美国专利申请16/250,484、美国专利9,139,802、美国专利9,175,250和/或美国专利8,785,361中所述,这些专利申请全文以引用方式并入本文。
纤维网形成材料可包括表现出适于制备纤维或长丝的特性的任何合适的物质。纤维网形成材料的非限制性示例可包括聚合物、多元醇、糖、糖醇以及它们的组合。纤维网可包含两种或更多种不同的纤维网形成材料。纤维网可包含三种或更多种不同的纤维网形成材料。聚合物可用作纤维网形成材料,并且在某些实施方案中还可提供口腔健康有益效果。
纤维组合物可包含按该纤维组合物的重量计约1%至约100%,约2%至约50%,约5%至约35%,约5%至约20%,约1%至约15%或约5%至约10%的非织造纤维网形成材料。
口腔护理组合物可包含按该口腔护理组合物的总重量计约1%至约80%,约1%至约50%,约1%至约25%,约2%至约20%,约3%至约15%,小于约10%或约5%至约10%的纤维网形成材料。
聚合物
口腔护理组合物可包含聚合物。纤维网形成材料可包含聚合物。纤维组合物或非纤维组合物可包含聚合物。泡沫组合物可包含聚合物。聚合物的非限制性示例可包括天然来源的聚合物、合成聚合物以及它们的组合。
天然来源的聚合物的非限制性示例可包括藻酸盐、树胶、基于蛋白质的聚合物、基于淀粉的聚合物、天然淀粉、改性淀粉、纤维聚合物、其他天然来源的聚合物以及它们的组合。
藻酸盐的非限制性示例可包括藻酸铵、藻酸钙、藻酸钾、丙二醇藻酸盐以及它们的组合。
树胶的非限制性示例可包括阿拉伯树胶、角叉菜胶、黄蓍胶、瓜尔胶、刺槐豆胶、黄原胶、结冷胶以及它们的组合。
基于蛋白质的聚合物的非限制性示例可包括乳清分离蛋白、大豆分离蛋白、卵清蛋白、酪蛋白、胶原、谷蛋白、明胶、麸质蛋白、玉米蛋白以及它们的组合。
基于淀粉的聚合物的非限制性示例可包括来源于谷物、块茎、根、豆类、果实以及它们的组合的那些基于淀粉的聚合物。基于淀粉的聚合物可包括以α1,4键连接的葡萄糖单体、直链淀粉、支链淀粉以及它们的组合。
天然淀粉的非限制性示例可包括蜡质或高淀粉酶品种的玉米、豌豆、马铃薯、香蕉、大麦、小麦、大米、西米、苋菜、木薯、竹芋、美人蕉、高粱以及它们的组合。
改性淀粉的非限制性示例可包括羟丙基淀粉、麦芽糖糊精、高直链淀粉以及它们的组合。
纤维聚合物的非限制性示例可包括果胶、低聚果糖、菊粉、琼脂、β-葡聚糖、糊精、木质素、纤维素、非淀粉多糖、还原淀粉、聚卡波非、柑橘纤维以及它们的组合。
其他天然源聚合物的非限制性示例可包括琼脂、普鲁兰、甲壳质、脱乙酰壳多糖、紫胶以及它们的组合。
合成聚合物的非限制性示例可包括纤维素衍生物、卡波姆、聚甲基丙烯酸酯、其他合成聚合物以及它们的组合。
纤维素衍生物的非限制性示例可包括羟乙基甲基纤维素、羟丙基甲基纤维素、羟丙基纤维素、羟丙基乙基纤维素、甲基纤维素、羟丙基甲基纤维素以及它们的组合。
卡波姆的非限制性示例可包括卡波姆934、卡波姆934P、卡波姆940、卡波姆94、卡波姆1342、卡波姆共聚物、卡波姆均聚物、卡波姆互聚物以及它们的组合。一些卡波姆可以商品名934P NF聚合物、/>971P NF聚合物和/>974P NF聚合物商购获得。
聚甲基丙烯酸酯的非限制性示例可包括甲基丙烯酸铵共聚物、碱性丁基化甲基丙烯酸酯共聚物、甲基丙烯酸-甲基丙烯酸甲酯共聚物(1:1)、甲基丙烯酸-丙烯酸乙酯共聚物(1:1)、甲基丙烯酸-丙烯酸乙酯共聚物(1:1)、甲基丙烯酸-甲基丙烯酸甲酯共聚物(1:2)、聚丙烯酸酯分散体30%、甲基丙烯酸共聚物、甲基丙烯酸氨基酯共聚物、甲基丙烯酸胺基酯共聚物、甲基丙烯酸胺基酯共聚物分散体、丙烯酸乙酯和甲基丙烯酸甲酯共聚物以及它们的组合。一些聚甲基丙烯酸酯可以商品名E 12.5、/>E 100、/>E PO、/>L12.5P、/>L 12.5、/>L 100、/>L 100-55、/>L 30 D-55、S 12.5 P、/>S 12.5、/>S 100、/>FS 30D、/>RL12.5、/>RL 100、/>RL PO、/>RL 30D、/>RS 12.5、/>RS 100、/>RS PO、/>RS 30D、/>NE 30D、/>NE 40D、/>NM 30D、EazorylTM 30D、/>MAE 30DP、/>MAE 100P、/>93A和/>MP商购获得。
其他合成聚合物的非限制性示例可包括聚乙烯醇、羧乙烯基聚合物、聚乙烯吡咯烷酮、聚环氧乙烷、聚氧乙烯以及它们的组合。
可选择本发明的聚合物,使得其重均分子量为约20,000道尔顿(Da)至约10,000,000Da,约100,000Da至约5,000,000Da,约500,000Da至约4,000,000Da或约1,000,000Da至约3,000,000Da。通过计算每种非织造纤维网形成材料原料的重均分子量与它们相应的按长丝内存在的聚合物总重量计的相对重量百分比的乘积的和来计算重均分子量。
聚合物可为重均分子量为约10,000Da至约250,000Da,在另一个实施方案中约15,000Da至约200,000Da,以及在另一个实施方案中约20,000Da至约150,000Da的聚乙烯醇。
聚乙烯醇可具有约60%至100%,约65%至约85%,小于85%,约70%至约80%或约65%至约95%的水解度。
聚合物可选自藻酸盐、基于淀粉的聚合物、天然淀粉、改性淀粉以及它们的组合,其具有约1,000,000Da至约6,000,000Da,约1,500,000Da至约5,000,000Da或约2,000,000Da至约4,000,000Da的重均分子量。
聚合物可选自聚乙烯醇、普鲁兰、果胶、玉米淀粉、改性玉米淀粉、羟丙基甲基纤维素以及它们的组合。
纤维组合物可包含按该纤维组合物的重量计约0.1%至约50%,约5%至约40%,约15%至约35%,约20%至约30%或约15%至约30%的聚合物。
非纤维组合物可包含按该非纤维组合物或口腔护理组合物的重量计约0.1%至约50%,约5%至约40%,约15%至约35%,约20%至约30%或约15%至约30%的聚合物。
增塑剂
口腔护理组合物可包含增塑剂。增塑剂的非限制性示例可包括多元醇、多元羧酸、聚酯、其他合适的增塑剂以及它们的组合。
多元羧酸的非限制性示例可包括柠檬酸、琥珀酸以及它们的组合。
聚酯的非限制性示例可包括甘油三乙酸酯、邻苯二甲酸二乙酯、柠檬酸三乙酯、柠檬酸三丁酯、柠檬酸乙酰基三乙酯、柠檬酸乙酰基三丁酯以及它们的组合。
本发明的其他合适增塑剂的非限制性示例包括但不限于邻苯二甲酸烷基酯和邻苯二甲酸烯丙基酯;乳酸盐(例如钠盐、铵盐和钾盐);乳酸;可溶的胶原;改性蛋白;L-谷氨酸单钠;蛋白质和氨基酸,诸如谷氨酸、天冬氨酸和赖氨酸;氢淀粉水解产物;其他低分子量酯(例如C2-C10醇和酸的酯);以及食品、膳食补充剂和制药工业领域技术人员已知的任何其他增塑剂;以及它们的组合。
多元醇
口腔护理组合物可包含多元醇。纤维组合物或非纤维组合物可包含多元醇。纤维网形成材料可包含多元醇。泡沫形成材料可包括多元醇。多元醇是具有多于一个羟基官能团的有机化合物。多元醇可包括糖醇、非还原糖、单糖、二糖、多糖和/或它们的组合。
糖醇是一类多元醇,其可通过具有式(CHOH)nH2的糖化合物的氢化获得,优选地其中n=2-6。合适的糖醇包括乙二醇、甘油、赤藓醇、苏糖醇、阿拉伯糖醇、木糖醇、核糖醇、甘露醇、山梨醇、半乳糖醇、岩藻糖醇、艾杜糖醇、肌醇、庚七醇、异麦芽酮糖醇、麦芽糖醇、乳糖醇、麦芽三糖醇、麦芽四糖醇和/或聚葡萄糖醇。
非还原糖是一类不生成任何包含醛官能团的化合物的糖。非还原糖在水中是稳定的,并且不与弱氧化剂反应产生糖醇。
单糖的非限制性示例可包括葡萄糖、果糖以及它们的组合。
二糖的非限制性示例可包括蔗糖、麦芽糖、乳糖、高果糖玉米糖浆固体、海藻糖、纤维二糖、龙胆二糖、异麦芽糖、曲二糖、昆布二糖、甘露二糖、蜜二糖、黑曲霉糖、芦丁二糖、木乙糖、乳果糖以及它们的组合。
丙糖的非限制性示例可包括甘油醛、二羟基丙酮以及它们的组合。
葡萄糖的非限制性示例可包括赤藓糖、苏糖、赤藓酮糖以及它们的组合。
戊糖的非限制性示例可包括阿拉伯糖、来苏糖、核糖、木糖、核酮糖、木酮糖以及它们的组合。
己糖的非限制性示例可包括阿洛糖、阿卓糖、半乳糖、葡萄糖、古洛糖、艾杜糖、甘露糖、塔罗糖、果糖、阿洛酮糖、山梨糖、塔格糖以及它们的组合。
庚糖的非限制性示例可包括甘露庚酮糖、景天庚酮糖以及它们的组合。
辛糖的非限制性示例可包括辛甲苯糖、2-酮基-3-脱氧-甘露-辛酸酯以及它们的组合。壬糖的非限制性示例可包括唾液糖。
口腔护理组合物可包含按该口腔护理组合物的重量计约0.01%至约50%,约0.1%至约50%,约1%至约40%,约2%至约25%,约5%至约15%或约5%至约10%的多元醇。
水
口腔护理组合物可包含按该口腔护理组合物的重量计约0.01%至约50%的水。口腔护理组合物可包含按该组合物的重量计约0.01%至约30%,约0.1%至约25%,约0.5%至约15%或约1%至约15%的水。水可直接添加到制剂中和/或可通过包含其他成分而进入组合物中。优选地,水为USP水。另选地,口腔护理组合物可包含按总体组合物的重量计少于约5%,少于约1%,少于约0.5%或少于约0.01%的水。除了掺入到口腔护理组合物中的商业产品中的最小量的水或在环境条件下掺入的水之外,口腔护理组合物可不包含添加的水。
磨料
口腔护理组合物可包含按该口腔护理组合物的重量计约0.5%至约75%的磨料。口腔护理组合物可包含按该组合物的重量计约5%至约60%,约10%至约50%,约15%至约55%或它们的组合的磨料。磨料可以是含钙磨料、二氧化硅磨料、碳酸盐磨料、磷酸盐磨料、氧化铝磨料、其他合适的磨料和/或它们的组合。一些磨料可归为若干描述性类别,诸如碳酸钙,其既为含钙磨料也为碳酸盐磨料。
含钙磨料可包括碳酸钙、磷酸二钙、磷酸三钙、正磷酸钙、偏磷酸钙、多磷酸钙、羟基磷灰石钙以及它们的组合。
含钙磨料可包括碳酸钙。含钙磨料可选自细磨天然白垩、研磨碳酸钙、沉淀碳酸钙以及它们的组合。
碳酸盐磨料可包括碳酸钠、碳酸氢钠、碳酸钙、碳酸锶和/或它们的组合。
磷酸盐磨料可包括磷酸钙、六偏磷酸钠、磷酸二钙、磷酸三钙、正磷酸钙、偏磷酸钙、多磷酸钙、多磷酸盐、焦磷酸盐和/或它们的组合。
二氧化硅磨料可包括熔融二氧化硅、热解法二氧化硅、沉淀二氧化硅、二氧化硅水合物和/或它们的组合。
氧化铝磨料可包括多晶氧化铝、煅烧氧化铝、熔融氧化铝、矿化氧化铝、水合氧化铝和/或它们的组合。
其他适宜的磨料包括硅藻土、硫酸钡、硅灰石、珍珠岩、聚甲基丙烯酸甲酯颗粒、球形有机硅以及它们的组合。
磨料可在纤维组合物内形成,添加到纤维组合物的表面,或包含在非纤维组合物中。
氟离子源
口腔护理组合物可包含有效量的抗龋齿剂。口腔护理组合物可包含氟离子源。
氟离子源的存在量可以足以根据当地法律和法规(例如,FDA的抗龋齿专著)在组合物中给出合适的氟离子浓度。口腔护理组合物可包含按该口腔护理组合物的重量计约0.0025%至约20%,约0.0025%至约10%,约0.01%至约5%或约0.0025%至约2%的氟离子源。
氟离子源的量适于获得如通过加入水归一化至单位剂量口腔护理组合物的约200ppm至约10000ppm,约200ppm至约2000ppm,约800ppm至约1500ppm或约1100ppm至约1400ppm的理论氟浓度。
氟离子源可包括美国专利3,535,421和3,678,154中公开的适于产生氟离子的物质的示例。氟离子源可包括氟化亚锡、氟化钠、氟化钾、氟化胺、单氟磷酸钠、氟化锌和/或它们的组合。
氟离子源和金属离子源可为相同的化合物,例如,氟化亚锡,其可生成锡离子和氟离子。另外,氟离子源和锡离子源可为单独的化合物,诸如当金属离子源为氯化亚锡并且氟离子源为单氟磷酸钠或氟化钠时。
氟离子源可在纤维组合物内形成,添加到纤维组合物的表面,或包含在非纤维组合物中。
金属离子源
口腔护理组合物可包含金属离子源。合适的金属离子源包括亚锡离子源、锌离子源、铜离子源、银离子源、镁离子源、铁离子源、钠离子源、和锰(Mn)离子源和/或它们的组合。所述金属离子源可为具有无机或有机反离子的可溶性或难溶性亚锡、锌或铜化合物。示例包括亚锡、锌和铜的氟化物、氯化物、氟氯化物、乙酸盐、六氟锆酸盐、硫酸盐、酒石酸盐、葡糖酸盐、柠檬酸盐、苹果酸盐、甘氨酸盐、焦磷酸盐、偏磷酸盐、草酸盐、磷酸盐、碳酸盐和氧化物。
亚锡离子、锌离子和铜离子来源于金属离子源,其可以有效量存在于多相口腔护理组合物中以提供口腔护理有益效果或其他有益效果。已发现,亚锡离子、锌离子和铜离子有助于减少齿龈炎、牙斑、过敏,并且有助于经改善的口气清新有益效果。有效量定义为总组合物中至少约500ppm至约20,000ppm,优选地约2,000ppm至约15,000ppm的金属离子。更优选地,金属离子的含量为约3,000ppm至约13,000ppm,甚至更优选地约5,000ppm至约10,000ppm。这是组合物中存在的用于递送至牙齿表面的金属离子(亚锡、锌、铜以及它们的混合物)的总量。
其他金属离子源可包括矿物质和/或含钙化合物,其可导致再矿化,例如碘化钠、碘化钾、氯化钙、乳酸钙、磷酸钙、羟基磷灰石、氟磷灰石、无定形磷酸钙、结晶磷酸钙、碳酸氢钠、碳酸钠、碳酸钙、草酸、草酸二钾、草酸氢一钾钠、酪蛋白磷酸肽和/或酪蛋白磷酸肽包被的羟基磷灰石。
金属离子源可包括适用于在口腔中生成金属离子的金属盐。合适的金属盐包括银(Ag)盐、镁(Mg)盐、铁(Fe)盐、钠(Na)盐和锰(Mn)盐,或它们的组合。优选的盐包括但不限于葡糖酸盐、氯酸盐、柠檬酸盐、氯化物、氟化物和硝酸盐或它们的组合。
口腔护理组合物可包含按该口腔护理组合物的重量计至少约0.005%,约0.005%至约10%,约0.01%至约5%,约0.01%至约2%或约0.1%至约1%的金属离子源。金属离子源可在纤维组合物内形成,添加到纤维组合物的表面,或包含在非纤维组合物中。
锡离子源
锡离子诸如亚锡离子用于口腔护理组合物中以递送有益效果,诸如釉质护理和龋齿保护。合适的锡离子源包括氯化亚锡、氟化亚锡、溴化亚锡、碘化亚锡、乙酸亚锡、葡糖酸亚锡、草酸亚锡、硫酸亚锡、乳酸亚锡、酒石酸亚锡、碳酸亚锡、氯化锡、氟化锡、碘化锡、柠檬酸亚锡、硝酸锡、亚锡肽、亚锡蛋白质和磷酸亚锡以及它们的组合。优选地,离子源为氟化亚锡、氯化亚锡以及它们的组合。
本发明的口腔护理组合物可包含量的范围在约0.01%至约5%,约0.05%至约4%,约0.01%至约10%或约0.075%至约3%内的锡离子源。锡离子源可在纤维组合物内形成,添加到纤维组合物的表面,或包含在非纤维组合物中。
锌离子源
口腔护理组合物可包含按该口腔护理组合物的重量计约0.01%至约5%,约0.2%至约2%或约0.01%至约10%的锌离子源。锌离子源可选自柠檬酸锌、氯化锌、硫酸锌、葡糖酸锌、乳酸锌、磷酸锌、氧化锌、精氨酸锌、氟化锌、碘化锌、碳酸锌以及它们的组合。更优选地,锌离子源选自柠檬酸锌、葡萄糖酸锌、乳酸锌、以及它们的组合。可使用不溶性或微溶性锌化合物诸如氧化锌或碳酸锌作为锌离子源。锌源可为可溶性锌源,诸如氯化锌或硫酸锌。另外,锌离子源可以是其中锌已经与盐或其他络合物形式的合适的螯合剂结合的那些,诸如柠檬酸锌、葡糖酸锌、乳酸锌和甘氨酸锌。锌离子源的其他示例是柠檬酸锌、葡糖酸锌、乳酸锌以及它们的混合物。
当不溶性和可溶性锌化合物均存在于锌离子源中时,可溶性锌化合物可以按总锌离子源的重量计至少约50%存在。本发明的口腔护理组合物还可任选地包含其他抗菌剂,该抗菌剂优选地以按该口腔护理组合物的重量计约0.035%或以上,约0.05%至约2%,约0.1%至约1%的量存在。这些其它抗菌剂的示例可包括非阳离子抗菌剂,诸如例如卤代二苯基醚、酚类化合物(包括苯酚及其同系物)、一烷基和多烷基卤代酚以及芳族卤代酚、间苯二酚及其衍生物、木糖醇、双酚化合物和卤代N-水杨酰苯胺、苯甲酸酯和卤代N-碳酰二苯胺。其它有用的抗菌剂是酶,包括内切糖苷酶、木瓜蛋白酶、葡聚糖酶、突变酶、以及它们的组合。在另一个示例中,其他抗菌剂可包括三氯生(5-氯-2-(2,4-二氯苯氧基)苯酚)。
锌离子源可在纤维组合物内形成,添加到纤维组合物的表面,或包含在非纤维组合物中。
铜离子源
口腔护理组合物可包含按该口腔护理组合物的重量计约0.01%至约5%,约0.2%至约2%或约0.01%至约10%的铜离子源。铜离子源可选自葡糖酸铜、柠檬酸铜、氟化铜、碘化铜、溴化铜、铜肽、硫酸铜、精氨酸铜、碳酸铜以及它们的组合。铜盐可为任何可能的氧化态,包括例如铜(I)或铜(II)盐。铜离子源可在纤维组合物内形成,添加到纤维组合物的表面,或包含在非纤维组合物中。
钙离子源
口腔护理组合物可包含钙离子源。钙离子源可包括钙盐,诸如氯化钙和/或含钙磨料,如本文所述。
钙化合物可包括任何合适的可溶性钙盐,诸如氯化钙、碳酸钙、碳酸氢钙、氢氧化钙、乳酸钙、柠檬酸钙、磷酸钙以及它们的组合。
口腔护理组合物可包含按该口腔护理组合物的重量计约0.01%至约10%,约1%至约50%,约10%至约50%或约1%至约30%的钙离子源。
表面活性剂
口腔护理组合物可包含一种或多种表面活性剂。纤维组合物可包含一种或多种表面活性剂。非纤维组合物可包含一种或多种表面活性剂。一种或多种表面活性剂可选自阴离子表面活性剂、非离子表面活性剂、两性表面活性剂、两性离子表面活性剂、阳离子表面活性剂或它们的组合。
口腔护理组合物可包含按该组合物的重量计约0.01%至约20%,约1%至约15%,约0.1%至约15%,约5%至约15%或大于约5%的含量的一种或多种表面活性剂。
合适的阴离子表面活性剂包括例如烷基中具有8至20个碳原子的烷基硫酸的水溶性盐和具有8至20个碳原子的脂肪酸的磺化单酸甘油酯的水溶性盐。这类阴离子表面活性剂的示例是月桂基硫酸钠(SLS)和椰子基单酸甘油酯磺酸钠。其他适宜的阴离子表面活性剂包括肌氨酸盐如月桂酰肌氨酸钠、牛磺酸盐、月桂基磺基乙酸钠、月桂酰羟乙基磺酸钠、月桂基聚氧乙烯醚羧酸钠和十二烷基苯磺酸钠。也可使用阴离子表面活性剂的组合。
另一类合适的阴离子表面活性剂是烷基磷酸盐。这些表面活性有机磷酸酯试剂对釉质表面可具有强亲和力,并且具有充分的表面结合倾向,以使表膜蛋白质解吸,并且保持附连到釉质表面。有机磷酸酯化合物的合适的示例包括由下列通式结构表示的单酯、二酯或三酯,其中Z1、Z2或Z3可相同或不同,其中至少一个为有机部分。Z1、Z2或Z3可选自1至22个碳原子的直链或支链烷基或烯基基团,任选地被一个或多个磷酸酯基团取代;烷氧基化烷基或烯基、(多)糖、多元醇或聚醚基团。
一些其他试剂包括由以下结构表示的烷基或烯基磷酸酯:
其中R1表示具有6至22个碳原子的直链或支链烷基或烯基基团,其任选地被一个或多个磷酸酯基团取代;n和m独立地并且单独地为2至4,并且a和b立地并且单独地为0至20;Z和Z可相同或不同,各自表示氢、碱金属、铵、质子化烷基胺或质子化官能烷基胺,诸如链烷醇胺或R-(OCH2)(OCH)-基团。合适试剂的示例包括烷基磷酸酯和烷基(聚)烷氧基磷酸酯如月桂基磷酸酯;PPGS鲸蜡硬脂基聚氧乙烯醚-10磷酸酯;月桂基聚氧乙烯醚-1磷酸酯;月桂基聚氧乙烯醚-3磷酸酯;月桂基聚氧乙烯醚-9磷酸酯;三月桂基聚氧乙烯醚-4磷酸酯;C12-18PEG9磷酸酯:和二月桂基聚氧乙烯醚-10磷酸钠。烷基磷酸盐可以是聚合物的。聚合烷基磷酸酯的示例包括含有重复的烷氧基作为聚合部分的那些,具体地包含3个或更多个乙氧基、丙氧基、异丙氧基或丁氧基的那些。
其他合适的表面活性剂是肌氨酸盐、羟乙基磺酸盐和牛磺酸盐,尤其是其碱金属盐或铵盐。示例包括:月桂酰肌氨酸盐、肉豆寇酰肌氨酸盐、棕榈酰肌氨酸盐、硬脂酰肌氨酸盐、油酰肌氨酸盐或它们的组合。
可用于本文的两性离子表面活性剂或两性表面活性剂包括脂族季铵、鏻和锍化合物的衍生物,其中脂族基团可以是直链或支链的,并且脂族取代基之一含有8至18个碳原子,并且脂族取代基之一含有阴离子水增溶基团,例如,羧基、磺酸根、硫酸根、磷酸根或膦酸根。合适的甜菜碱表面活性剂公开于美国专利5,180,577中。典型的烷基二甲基甜菜碱包括癸基甜菜碱或2-(N-癸基-N,N-二甲基胺)乙酸酯、椰油基甜菜碱或2-(N-椰油基-N,N-二甲基胺)乙酸酯、十四烷基甜菜碱、棕榈基甜菜碱、月桂基甜菜碱、十六烷基甜菜碱、十六烷基甜菜碱、硬脂基甜菜碱等。酰胺基甜菜碱可由椰油酰胺基乙基甜菜碱、椰油酰胺基丙基甜菜碱(CADB)和月桂酰胺基丙基甜菜碱举例说明。
可用于本发明中的阳离子表面活性剂包括例如具有一条包含8至18个碳原子的长烷基链的季铵化合物衍生物,诸如月桂基三甲基氯化铵;十六烷基氯化吡啶鎓;十六烷基三甲基溴化铵;十六烷基氟化吡啶鎓或它们的组合。
可用于本发明组合物中的非离子表面活性剂包括例如由环氧烷基团(本身亲水的)与本身可为脂族或烷基芳族的有机疏水化合物缩合而生成的化合物。合适的非离子表面活性剂的示例可包括(即泊洛沙姆)、烷基酚的聚环氧乙烷缩合物、衍生自环氧乙烷与环氧丙烷和乙二胺的反应产物的缩合的产物、脂肪醇的环氧乙烷缩合物、长链叔胺氧化物、长链叔膦氧化物、长链二烷基亚砜以及这些物质的组合。
一种或多种表面活性剂还可包括一种或多种天然表面活性剂。天然表面活性剂可包括源自天然产物的表面活性剂和/或最小程度加工或未加工的表面活性剂。天然表面活性剂可包括:氢化的、非氢化的或部分氢化的蔬菜油、植物油、西番莲油、小烛树蜡、椰油基辛酸酯、癸酸酯、二辛醚、月桂醇、肉豆蔻酸十四烷基酯、二辛醚、辛酸、辛酯、癸酸辛酯、辛酸辛酯、十一烷、十三烷、油酸癸酯、癸基油酸酯、棕榈酸十六烷基酯、硬脂酸、棕榈酸、硬脂酸甘油酯、氢化的、非氢化的或部分氢化的植物甘油酯、聚甘油-2二多羟基硬脂酸酯、十六/十八醇、蔗糖聚硬脂酸酯、甘油、十八烷醇、水解的、部分水解的或未水解的植物蛋白、水解的、部分水解的或未水解的小麦蛋白水解产物、聚甘油基-3二异硬脂酸酯、油酸甘油酯、肉豆蔻醇、十六烷醇、十六烷硬脂基硫酸钠、十六烷硬脂醇、月桂酸甘油酯、癸酸甘油三酯、椰油基甘油酯、卵磷脂、二辛醚、黄原胶、椰油硫酸钠、十二烷基硫酸铵、椰油基硫酸钠、椰油基谷氨酸钠、多烷基葡糖苷诸如癸基葡糖苷、十六烷硬脂基葡糖苷、十六烷硬脂基多葡糖苷、椰油基葡糖苷和月桂基葡糖苷和/或它们的组合。天然表面活性剂可包括由BASF出售的天然成分中的任一种,例如 /> 和/或它们的组合。
表面活性剂可在纤维组合物内形成,添加到纤维组合物的表面,和/或包含在非纤维组合物中。在纤维组合物内形成的表面活性剂可以按该纤维组合物的重量计约10%至约50%,约20%至约40%,约25%至约40%或约30%至约40%的含量存在。
口腔护理组合物可包含一种或多种表面活性剂。口腔护理组合物可包含阴离子表面活性剂、阳离子表面活性剂、非离子表面活性剂和/或两性离子表面活性剂。
口腔护理组合物可包含按该组合物的重量计约0.1%至约10%,约0.1%至约8%,约5%至约8%,约4%至约9%或约3%至约10%的阴离子表面活性剂、阳离子表面活性剂和/或非离子表面活性剂。
口腔护理组合物可包含按该组合物的重量计约0.01%至约20%,约0.01%至约10%,约0.1%至约1%,约0.01%至约1%,约0.01%至约0.5%或约0.1%至约0.2%的两性离子表面活性剂。
PEG
口腔护理组合物可包含聚乙二醇(PEG),其具有占该组合物的不同重量百分比以及各种平均分子量范围。该组合物可具有按该组合物的重量计约0.1%至约40%,约1%至约35%,约5%至约30%,约15%至约25%,约1%至约40%,约10%至约30%,约15%至约20%,约0.1%至约30%或约15%至约30%的PEG。PEG可具有约100道尔顿至约1600道尔顿,约200至约1000,约400至约800,约500至约700道尔顿或它们的组合的平均分子量范围。PEG是通过环氧乙烷与具有以下通式的乙二醇等同物的加成反应形成的水溶性线型聚合物:H-(OCH2CH2)n-OH。PEG的一个供应商是CARBOWAXTM品牌的DowChemicalCompany。
PEG可在纤维组合物内形成,添加到纤维组合物的表面,或包含在非纤维组合物中。包含在非纤维组合物内的PEG可以按该非纤维组合物的重量计约10%至约50%,约15%至约40%,约5%至约35%或约15%至约30%的含量存在。当用作非纤维组合物的溶剂时,PEG可以是无水的,以防止分散或溶解在PEG内的组分之间的反应性。
多磷酸盐
口腔护理组合物可包含多磷酸盐源。多磷酸盐源可包含一个或多个多磷酸盐分子。多磷酸盐是一类通过正磷酸盐脱水和缩合生成不同链长的直链和环状多磷酸盐而获得的物质。因此,多磷酸盐分子通常以多磷酸盐分子的平均数(n)来标识,如下所述。尽管可存在一些环状衍生物,但通常认为多磷酸盐由主要以线性构型排列的两个或更多个磷酸盐分子组成。
优选的多磷酸盐是那些具有平均两个或更多个磷酸基团的多磷酸盐,以使得有效浓度的表面吸附产生足够的未结合的磷酸根官能团,这增强了阴离子表面电荷以及表面的亲水特性。本发明中优选的是具有下式的直链多磷酸盐:XO(XPO3)nX,其中X为钠、钾、铵或任何其他碱金属阳离子,并且n平均为约2至约21。由于能够从其他反应性组分如氟离子源中分离钙离子,该多磷酸盐源还可包括碱土金属多磷酸盐,并且具体地包括多磷酸钙盐诸如焦磷酸钙。
合适的多磷酸盐分子的一些示例包括例如焦磷酸盐(n=2)、三聚磷酸盐(n=3)、四聚磷酸盐(n=4)、多磷酸钠磷(n=6)、六聚磷酸盐(n=13)、苯多磷酸盐(n=14)、六偏磷酸盐(n=21),其还被称为Glass H.多磷酸盐,可包括由FMC Corporation、ICLPerformance Products和/或Astaris生产的那些多磷酸盐化合物。
口腔护理组合物可包含按该口腔护理组合物的重量计约0.01%至约15%,约0.1%至约10%,约0.5%至约5%,约1%至约20%或约10%或更少的多磷酸盐源。
延伸助剂
口腔护理组合物可包含延伸助剂。延伸助剂的非限制性示例可包括聚合物、其它延伸助剂、以及它们的组合。
延伸助剂可具有至少约500,000Da的重均分子量。延伸助剂的重均分子量可为约500,000至约25,000,000,约800,000至约22,000,000,约1,000,000至约20,000,000或约2,000,000至约15,000,000。高分子量延伸助剂在本发明的一些实施方案中是优选的,这是由于其提高延伸熔融粘度并减少熔融破裂的能力。
当用于熔喷时,可将有效量的延伸助剂添加到本发明的组合物中以视觉上减少纺丝工艺期间的长丝的熔体破裂和毛细管破碎,使得能够熔纺出具有相对一致直径的基本上连续的长丝。无论用于制备长丝的方法如何,当使用时,延伸助剂可以基于干燥长丝按重量计约0.001%至约10%,基于干燥长丝按重量计约0.005%至约5%,基于干燥长丝按重量计约0.01%至约1%或基于干燥长丝按重量计约0.05%至约0.5%的含量存在。
可用作延伸助剂的聚合物的非限制性示例可任选地包括藻酸盐、角叉菜胶、果胶、甲壳质、瓜尔胶、黄多醣胶、琼脂、阿拉伯树胶、刺梧桐树胶、黄蓍胶、刺槐豆胶、烷基纤维素、羟烷基纤维素、羧基烷基纤维素以及它们的混合物。
其他延伸助剂的非限制性示例可包括羟基改性的聚丙烯酰胺、聚丙烯酸、聚甲基丙烯酸、聚乙烯醇、聚乙酸乙烯酯、聚乙烯吡咯烷酮、聚乙烯乙酸乙烯酯、聚乙烯亚胺、聚酰胺、聚环氧烷包括聚环氧乙烷、聚环氧丙烷、聚乙烯环氧丙烷以及它们的混合物。
美化剂
口腔护理组合物可任选地包含一种或多种美化剂。该一种或多种美化剂可选自风味剂、着色剂、感觉剂、甜味剂、流涎剂以及它们的组合。所有美化剂可以按该口腔护理组合物的重量计约0.001%至约60%,按该口腔护理组合物的重量计约0.005%至约50%,按该口腔护理组合物的重量计约0.05%至约40%或按该口腔护理组合物的重量计约0.1%至约35%的量存在。
美化剂可在纤维组合物内形成,添加到纤维组合物的表面,或包含在非纤维组合物中。
风味剂
口腔护理组合物可任选地包含一种或多种风味剂。可用于本发明的风味剂的非限制性示例可包括天然调味剂、人造调味剂、人造提取物、天然提取物以及它们的组合。风味剂的非限制性示例可包括香草、蜂蜜、柠檬、柠檬蜂蜜、樱桃香草、桃、蜜姜、洋甘菊、樱桃、樱桃奶油、薄荷、香草薄荷、浆果、黑莓、树莓、胡椒薄荷、留兰香、蜂蜜桃、巴西莓、越橘、蜂蜜越橘、热带水果、火龙果、雪果、红干薄荷、石榴、黑加仑、草莓、柠檬、酸橙、桃姜、橙、橙奶油、奶油冰棒、杏、茴香、姜、榴莲、杨桃、蓝莓、果酒、柠檬草、洋甘菊柠檬草、薰衣草、香蕉、草莓香蕉、葡萄、紫蓝莓、柠檬莱姆、咖啡、浓缩咖啡、卡布奇诺、蜂蜜、冬青薄荷、泡泡糖、酸蜂蜜柠檬、酸柠檬、绿苹果、波西莓、红莓、草莓大黄、柿子、绿茶、红茶、白茶、蜂蜜酸橙、樱桃酸橙、苹果、橘子、葡萄柚、猕猴桃、梨、香草精、乙基香兰素、麦芽醇、乙基麦芽醇、南瓜、胡萝卜饼、白巧克力树莓、巧克力、白巧克力、牛奶巧克力、黑巧克力、巧克力棉花软糖、苹果派、肉桂、榛子、杏仁、奶油、法式焦糖布丁、焦糖、焦糖坚果、黄油、太妃糖、焦糖太妃糖、芦荟、威士忌、朗姆、可可、甘草、菠萝、番石榴、甜瓜、西瓜、接骨木莓、口腔清爽剂、树莓奶油、桃芒果、热带植物、冷莓、柠檬冰、花蜜、辛辣花蜜、热带芒果、苹果黄油、花生酱、橘子、橘子酸橙、棉花软糖、棉花糖、苹果汁、橙子巧克力、己二酸、柠檬醛、苯甲地那铵、乙酸乙酯、乳酸乙酯、乙基麦芽酚、乙基纤维素、富马酸、亮氨酸、苹果酸、薄荷醇、甲硫氨酸、谷氨酸一钠、乙酸钠、乳酸钠、酒石酸、百里酚以及它们的组合。
风味剂可在包封物中或作为风味剂晶体进行保护。一旦包封的风味剂到达口腔,包封的风味剂可具有受控或延迟的释放。包封物可包括壳和芯。风味剂可在包封物的芯中。风味剂可通过任何合适的方式诸如喷雾干燥或挤出来包封。包封的风味剂可添加到纤维组合物的表面,在纤维组合物内形成,或包含在非纤维组合物中。
风味剂可以按该口腔护理组合物的重量计约0.05%至约25%,按该口腔护理组合物的重量计约0.01%至约15%,按该口腔护理组合物的重量计约0.2%至约10%或按该口腔护理组合物的重量计约0.1%至约5%的量存在。
风味剂可在纤维组合物内形成,添加到纤维组合物的表面,或包含在非纤维组合物中。
着色剂
口腔护理组合物可任选地包含一种或多种着色剂。当口腔护理组合物暴露于预期用途条件时,着色剂可提供视觉信号。可用于本发明的着色剂的非限制性示例包括FD&C蓝#1、FD&C蓝#2、D&C蓝#4、D&C蓝#9、FD&C绿#3、D&C绿#5、D&C绿#6、D&C绿#8、D&C橙#4、D&C橙#5、D&C橙#10、D&C橙#11、FD&C红#3、FD&C红#4、D&C红#6、D&C红#7、D&C红#17、D&C红#21、D&C红#22、D&C红#27、D&C红#28、D&C红#30、D&C红#31、D&C红#33、D&C红#34、D&C红#36、D&C红#39、FD&C红#40、D&C紫#2、FD&C黄#5、FD&C黄#6、D&C黄#7、Ext.D&C黄#7、D&C黄#8、D&C黄#10、D&C黄#11以及它们的组合。着色剂按该口腔护理组合物的重量计约0.05%至约2%,按该口腔护理组合物的重量计约0.01%至约2%或按该口腔护理组合物的重量计约0.02%至约1.5%的量存在。
着色剂可在纤维组合物内形成,添加到纤维组合物的表面,或包含在非纤维组合物中。
感觉剂
口腔护理组合物可任选地包含一种或多种感觉剂。感觉剂的非限制性示例可包括凉爽感觉剂、温热感觉剂、麻刺感觉剂以及它们的组合。感觉剂可用于向使用者递送信号。
凉爽感觉剂的非限制性示例可包括WS-23(2-异丙基-N,2,3-三甲基丁酰胺)、WS-3(N-乙基对薄荷烷-3-甲酰胺)、WS-30(1-甘油基对薄荷烷-3-羧酸酯)、WS-4(乙二醇对薄荷烷-3-羧酸酯)、WS-14(N-叔丁基对薄荷烷-3-甲酰胺)、WS-12(N-(4-乙氧基苯基)对薄荷烷-3-甲酰胺)、WS-5(乙基-3-(对薄荷烷-3-甲酰胺基)乙酸酯、薄荷酮甘油缩酮(由Haarmann&Reimer以MGA出售)、(-)-乳酸薄荷酯(由Haarmann&Reimer以/>ML出售)、(-)-薄荷氧基丙-1,2-二醇(由Takasago International以Coolant Agent 10出售)、3-(l-薄荷氧基)丙-1,2-二醇、3-(l-薄荷氧基)-2-甲基丙-1,2-二醇、(-)-异蒲勒醇由Takasago International.以商品名“Coolact/>”出售,顺式和反式对薄荷烷-3,8-二醇(PMD38)-Takasago International,/>(吡咯烷酮羧酸薄荷酯),(1R,3R,4S)-3-薄荷基-3,6-二氧杂庚酸酯-Firmenich,(1R,2S,5R)-3-薄荷基甲氧基乙酸酯-Firmenich,(1R,2S,5R)-3-薄荷基-3,6,9-三氧杂癸酸酯-Firmenich,(1R,2S,5R)-11-羟基-3,6,9-三氧杂十一酸酯-Firmenich,(1R,2S,5R)-3-薄荷基(2-羟基乙氧基)乙酸酯-Firmenich,Cubebol-Firmenich,冰素也称为AG-3-5,化学名1-[2-羟基苯基]-4-[2-硝基苯基]-1,2,3,6-四氢嘧啶-2-酮、4-甲基-3-(1-吡咯烷基)-2[5H]-呋喃酮、Frescolat ML-乳酸薄荷酯、Frescolat MGA-薄荷酮甘油缩醛、薄荷油、Givaudan 180、L-琥珀酸单薄荷酯、L-戊二酸单薄荷酯、3-l-薄荷氧基丙烷-1,2-二醇-(Coolact 10)、2-l-薄荷氧基乙醇(Cooltact 5)、TK10 Coolact(3-l-薄荷氧基丙烷-1,2-二醇)、Evercool 180(N-对苯乙腈基-薄荷烷甲酰胺)以及它们的组合。凉爽感觉剂按该口腔护理组合物的重量计约0.005%至约10%,按该口腔护理组合物的重量计约0.05%至约7%或按该口腔护理组合物的重量计约0.01%至约5%的量存在。
温热感觉剂的非限制性示例可包括TK 1000、TK 1MM、Heatenol-Sensient风味剂、Optaheat-Symrise风味剂、肉桂、聚乙二醇、辣椒、辣椒素、咖喱、FSI风味剂、异丁醇、乙醇、甘油、烟酰胺60162807、Hotact VEE、Hotact 1MM、胡椒碱、optaheat 295 832、optaheat204 656、optaheat 200 349以及它们的组合。温热感觉剂可基于干燥长丝按重量计约0.005%至约60%,基于干燥长丝按重量计约0.05%至约50%或基于干燥长丝按重量计约0.01%至约40%的含量存在。温热感觉剂可按该口腔护理组合物的重量计约0.005%至约10%,按该口腔护理组合物的重量计约0.05%至约7%或按该口腔护理组合物的重量计约0.01%至约5%的量存在。
麻刺感觉剂的非限制性示例可包括花椒、羟基α山椒素、柠檬酸、金钮扣提取物、千日菊酰胺以及它们的组合。麻刺感觉剂可以基于干燥长丝重量计或基于口腔护理组合物重量计约0.005%至约10%,基于干燥长丝重量计或基于口腔护理组合物重量计约0.01%至约7%或基于干燥长丝重量计或基于口腔护理组合物重量计约0.015%至约6%的量存在。
感觉剂可在纤维组合物内形成,添加到纤维组合物的表面或包含在非纤维组合物中。
甜味剂
口腔护理组合物可任选地包含一种或多种甜味剂。甜味剂可以是天然的或人造的。甜味剂的非限制性示例可包括营养甜味剂、糖醇、合成甜味剂、高强度天然甜味剂以及它们的组合。所有甜味剂可按该口腔护理组合物的重量计约0.05%至约60%,按该口腔护理组合物的重量计约0.1%至约50%或按该口腔护理组合物的重量计约1%至约10%的量存在。
营养甜味剂的非限制性示例可包括蔗糖、右旋糖、葡萄糖、果糖、乳糖、塔格糖、麦芽糖、海藻糖以及它们的组合。营养甜味剂可按该口腔护理组合物的重量计约0.1%至约60%,按该口腔护理组合物的重量计约1%至约50%或按该口腔护理组合物的重量计约0.1%至约10%的量存在。
糖醇的非限制性示例可包括木糖醇、山梨醇、甘露醇、麦芽糖醇、乳糖醇、异麦芽酮糖醇、赤藓醇以及它们的组合。糖醇可按该口腔护理组合物的重量计约0.1%至约60%,按该口腔护理组合物的重量计约0.11%至约50%或按该口腔护理组合物的重量计约0.1%至约10%的量存在。
合成甜味剂的非限制性示例可包括天冬甜素、丁磺氨钾、阿力甜、糖精钠、三氯蔗糖、纽甜、环磺酸盐以及它们的组合。合成甜味剂可按该口腔护理组合物的重量计约0.05%至约10%,按该口腔护理组合物的重量计约0.1%至约5%或按该口腔护理组合物的重量计约0.25%至约4%的量存在。
高强度天然甜味剂的非限制性示例可包括新橙皮苷二氢查耳酮、蛇菊苷、莱鲍迪甙A、莱鲍迪甙C、杜尔可甙、甘草酸单铵、非洲甜果素以及它们的组合。高强度天然甜味剂可按该口腔护理组合物的重量计约0.05%至约10%,按该口腔护理组合物的重量计约0.1%至约5%或按该口腔护理组合物的重量计约0.25%至约4%的量存在。
甜味剂可在非织造纤维网内形成,添加到非织造纤维网的表面或包含在非纤维组合物中。
流涎剂
口腔护理组合物可任选地包含一种或多种流涎剂。流涎剂的非限制性示例包括式(I):
其中R1表示C1-C2正烷基;R2为2-甲基-1-丙基,并且R3为氢,或者R2和R3合在一起为具有式-(CH2)n-的部分(由虚线表示),其中n为4或5,以及它们的组合。
流涎剂可包括其中R2为2-甲基-1-丙基并且R3为氢的材料,或者流涎剂可包括其中R1为C1正烷基、R2为2-甲基-1-丙基并且R3为氢的材料。流涎剂可包括反式墙草碱,一种具有根据化学式(II)所述结构的化学物质:
流涎剂可包括碳酸氢钠、氯化钠、反式墙草碱、毛果芸香碱、柠檬酸盐以及它们的组合。流涎剂可按口腔护理组合物的重量计为约1%至约60%,约1%至约50%或约1%至约40%的含量存在。另外,流涎剂可按该口腔护理组合物的重量计约0.005%至约10%,按该口腔护理组合物的重量计约0.01%至约7%或按该口腔护理组合物的重量计约0.015%至约6%的量存在。
流涎剂可在纤维组合物内形成,添加到纤维组合物的表面或包含在非纤维组合物中。
增稠剂
本文的口腔护理组合物可包含一种或多种增稠剂。增稠剂可以按口腔护理组合物的重量计约0.01%至约15%,或约0.1%至约10%或约0.1%至约5%的量使用。非限制性示例可包括US 2008/0081023 A1第134至137段以及其中引用的参考文献中所述的那些。
口腔护理组合物可包含直链硫酸化多糖作为增稠剂。角叉菜胶或卡拉胶是直链硫酸化多糖的一个示例。一般来讲,角叉菜胶可基于硫酸化度而变化,包括:κ-角叉菜胶、Ι-角叉菜胶和λ-角叉菜胶。可使用角叉菜胶的组合。口腔护理组合物可包含按该口腔护理组合物的重量计约0.1%至约3%,约0.5%至约2%,约0.6%至约1.8%或它们的组合的直链硫酸化多糖。
口腔护理组合物可包含二氧化硅试剂,优选地由硅酸钠溶液通过用酸去稳定获得的增稠二氧化硅,以获得非常细小的颗粒。一个可商购获得的示例为得自HuberEngineered Materials的品牌二氧化硅(例如/>103、124、113、115、163、165、167)。口腔护理组合物可包含按该口腔护理组合物的重量计约0.5%至约5%,优选地约1%至约4%,另选地约1.5%至约3.5%,另选地约2%至约3%,另选地约2%至约5%,另选地约1%至3%,另选地它们的组合的二氧化硅试剂。
增稠剂可包含羧甲基纤维素(“CMC”)。CMC通过用碱和单氯乙酸或其钠盐处理而由纤维素制备。不同种类的商业特征为粘度。一个可商购获得的示例是AqualonTM品牌CMC,得自Ashland Special Ingredients(例如AqualonTM 7H3SF;AqualonTM 9M3SF AqualonTMTM9A;AqualonTM TM12A)。增稠剂可包含按该口腔护理组合物的重量计约0.1%至约3%,优选地约0.5%至约2%,另选地约0.6%至约1.8%,另选地它们的组合的CMC。
增稠剂可在纤维组合物内形成,添加到纤维组合物的表面,或包含在非纤维组合物中。
螯合剂
本发明的口腔护理组合物可任选地包含一种或多种螯合剂,其还被称为螯合试剂。如本文所用,术语“螯合剂”是指具有至少两个能够结合金属离子并且优选地能够结合其他二价或多价金属离子的基团的二齿或多齿配体,并且至少为螯合剂混合物一部分的螯合剂能够使口腔护理组合物中的锡离子或其他任选的金属离子增溶。能够结合金属离子的基团包括羧基、羟基和胺基团。
本文适宜的螯合剂包括C2-C6二羧酸和三羧酸,诸如琥珀酸、苹果酸、酒石酸和柠檬酸;被羟基取代的C3-C6一元羧酸,诸如葡糖酸;吡啶甲酸;氨基酸,诸如甘氨酸;它们的盐以及它们的混合物。螯合剂也可为其中螯合配体在相同或相邻单体上的聚合物或共聚物。
优选的螯合剂聚合物是多元酸,其选自:单体的均聚物、两种或更多种不同单体的共聚物以及它们的组合,其中该单体或该两种或更多种不同单体中的至少一种选自丙烯酸、甲基丙烯酸、衣康酸、马来酸、戊烯二酸、乌头酸、柠康酸、中康酸、富马酸和丁酸。尤其优选的是甲基乙烯基醚/马来酸(PVM/MA)共聚物。其他可用的螯合剂包括如本文所述的多磷酸盐。
本文优选的有机酸螯合剂包括柠檬酸根、苹果酸根、酒石酸根、葡糖酸根、琥珀酸根、乳酸根、丙二酸根、马来酸根以及它们的混合物,无论是以它们的游离酸形式还是盐形式加入。
本发明的口腔护理组合物可具有低含量的螯合剂,因为如果将金属离子引入到纤维组合物、非纤维组合物中,或与口腔护理组合物的其他反应性组分在物理上分离,则其可能需要较少的稳定性,这些其他反应性组分可加入到单独的纤维网层中或加入到非纤维组合物中。口腔护理组合物可具有按该口腔护理组合物的重量计少于约5%,少于约1%,少于约0.5%,少于约0.1%,少于约0.01%或0%的螯合剂。螯合剂可在纤维组合物内形成,添加到纤维组合物的表面,或包含在非纤维组合物中。
增白剂
口腔护理组合物还可包含按总口腔护理组合物的重量计约0.1%至约10%,约0.2%至约5%,约1%至约5%或约1%至约15%的增白剂。增白剂可为适于美白口腔中的至少一颗牙齿的化合物。增白剂可包括过氧化物、金属亚氯酸盐、过硼酸盐、过碳酸盐、过氧酸、过硫酸盐以及它们的组合。合适的过氧化物包括固体过氧化物、过氧化脲、过氧化钙、过氧化苯甲酰、过氧化钠、过氧化钡、无机过氧化物、氢过氧化物、有机过氧化物以及它们的混合物。适宜的金属亚氯酸盐包括亚氯酸钙、亚氯酸钡、亚氯酸镁、亚氯酸锂、亚氯酸钠和亚氯酸钾。其他合适的增白剂包括过硫酸钠、过硫酸钾、Peroxydone复合物(聚乙烯吡咯烷酮和过氧化氢)、6-苯二甲酰亚氨基过氧己酸、邻苯二甲酰亚胺过氧己酸或它们的混合物。
增白剂可与口腔护理组合物的其他组分反应,因此可使用本文所述的组合物设计与其他组分分离。增白剂可在纤维组合物内形成,添加到纤维组合物的表面,或包含在非纤维组合物中。
生物活性物质
口腔护理组合物还可包含适于牙齿再矿化的生物活性物质。合适的生物活性物质包括生物活性玻璃、NovaminTM、RecaldentTM、羟基磷灰石、氨基酸(例如,精氨酸、瓜氨酸、甘氨酸、赖氨酸或组氨酸)或它们的组合。其他合适的生物活性物质包括任何磷酸钙化合物。其他合适的生物活性物质包括包含钙源和磷酸盐源的化合物。
生物活性玻璃包含钙和/或磷酸盐,其可以类似于羟基磷灰石的比例存在。这些玻璃可粘结到组织并且是生物相容性的。生物活性玻璃可包含磷酸肽、钙源、磷酸盐源、二氧化硅源、钠源和/或它们的组合。
口腔护理组合物可包含按该口腔护理组合物的重量计约0.01%至约20%,约0.1%至约10%或约1%至约10%的生物活性物质。
生物活性物质可在纤维组合物内形成,添加到纤维组合物的表面或包含在非纤维组合物中。
非纤维组合物
本文所述的组分可任选地至少部分地作为非纤维组合物存在。非纤维组合物可介于两个或更多个纤维网层之间,折叠在至少一个纤维网层内,轧制在至少纤维网层内,或包裹在至少一个纤维网层内。非纤维组合物的至少一部分可接触纤维组合物的表面。非纤维组合物可为液体、固体、含水的和/或它们的组合。
非纤维组合物可包含口腔护理活性物质、美化剂、磨料、氟离子源、纤维网形成材料、金属离子源、多磷酸盐、螯合剂、抗牙结石剂、增稠剂、聚合物、表面活性剂、生物活性材料和/或它们的组合。
非纤维组合物可为按口腔护理组合物的重量计约10%至约90%,约20%至约85%,约30%至约80%,约40%至约75%,约50%至约80%,约50%至约90%或约60%至80%。
非纤维组合物的密度可为约0.05g/cm3至约5g/cm3,约0.75g/cm3至约1.9g/cm3,约1g/cm3至约1.75g/cm3或约1.4g/cm3至约1.8g/cm3。
涂料组合物
本文所述的组分可任选地至少部分地作为涂料组合物存在。可将涂料组合物施用到纤维组合物、纤维网或口腔护理组合物。涂料组合物至少部分地覆盖或覆盖纤维组合物或纤维网的外表面。涂料组合物可覆盖口腔护理组合物的外表面,从而在用于释放口腔护理活性物质和/或美化剂期间将涂料组合物置于适当位置以立即接触目标表面(例如,口腔中的唾液)。
本发明的涂料组合物可包含如本文所定义的一种或多种口腔护理活性物质。本发明的涂料组合物可包含如本文所定义的一种或多种美化剂。
纤维组合物、纤维网或口腔护理组合物可包含一种或多种口腔护理活性物质,其可与存在于涂料组合物中的口腔护理活性物质相同或不同。纤维组合物、纤维网或口腔护理组合物可包含延迟递送、延长递送口腔护理活性物质和/或定向递送口腔护理活性物质,并且涂料组合物包含即时递送口腔护理活性物质。纤维组合物、纤维网或口腔护理组合物可包含一种或多种美化剂,该一种或多种美化剂可与涂料组合物中的美化剂相同或不同。
涂料组合物也可被包埋在纤维组合物或纤维网内。因此,当使用任何合适的方式形成纤维网时,涂料组合物的颗粒可贴合在纤维或长丝之间的空隙内。
可释放组分
口腔护理活性物质、美化剂或口腔护理组合物中的其他组分可被设计成能够在合适的触发条件下释放。可释放组分能够在相同或不同的触发条件下释放。例如,风味剂包封物可能够在与使用者刷洗至少一颗牙齿相关联的剪切速率下释放。氟离子源可能够在与水接触时释放。这可允许口腔护理活性物质或美化剂在可指定的时间释放。例如,风味剂可在刷牙后1秒释放,而着色剂可在使用者刷牙两分钟后释放,以指示合适的刷牙时间已过去。美化剂或口腔护理活性物质可与其他美化剂或口腔护理活性物质顺序递送或同时递送。
图形
图形可直接印刷在口腔护理组合物上。合适的图形包括匹配风味的图形、运动队徽标或名称的图形、匹配使用说明的图形,诸如在一天中的特定时间、在食用某种食物或饮料之后或要使用的刷子的类型、营销材料、颜色、设计、徽标、描绘虚构和非虚构字符的图形、与消费者有益效果相关联的图形、标志、短语、口号、励志名言、品牌材料、公司信息、成分列表、动物或其他合适的图形,以直接传达关于口腔护理组合物的信息。图形可印刷在口腔护理组合物的每一侧上。在口腔护理组合物每一侧上的图形可相同或不同。
溶解时间
本发明的口腔护理组合物可由其溶解时间来描述。本发明的口腔护理组合物比能与之相比的糊剂洁齿剂溶解得快得多。根据如本文所述的溶解方法,包含本发明纤维组合物的口腔护理组合物可具有每剂量口腔护理组合物小于约1000秒,小于约750秒,小于约500秒,小于约250秒,约50秒至约250秒或约50秒至约500秒的总溶解时间。根据本文所述的溶解方法,本发明的泡沫组合物可具有每剂量泡沫组合物小于约50秒,小于约30秒或小于约20秒的总溶解时间。能与之相比的洁齿剂糊剂制剂具有大于1000秒的溶解时间,这不适用于在与口腔中的水分接触时需要溶解的单位剂量口腔护理组合物。
氟摄取
如本文所述,口腔护理组合物可根据其通过HAP溶解的平均氟摄取来描述。尽管本发明的口腔护理组合物还包含由于与氟离子的反应而通常避免或小心避免的组分,但其具有更高的平均F摄取。例如,口腔护理组合物尽管包含可在被消费者使用之前反应以形成沉淀氟化钙的氟离子源和钙离子源,但仍可具有至少1000ppm,至少1500ppm或至少2000ppm的平均氟摄取。如本文所述的口腔护理组合物在不同的非织造纤维网层中、在单独的部分中、在口腔护理组合物的单独的组合物中或在可溶性固相中在物理上将氟离子源与钙离子源分离。这些组分的物理分离先前一直是难以实现的。单位剂量口腔护理组合物(诸如小袋、固体泡沫或可溶性纤维组合物)提供基础结构,该基础结构可在储存期间在物理上将氟离子与钙离子分离,但也允许它们能够在口腔中溶解和/或崩解时组合。
锡离子摄取
如本文所述,口腔护理组合物可根据其通过HAP溶解的平均锡离子摄取来描述。尽管本发明的口腔护理组合物还包含由于与锡离子的反应而通常避免或小心配制的组分,但其具有更高的平均Sn摄取。例如,口腔护理组合物尽管包含可在被消费者使用之前反应以形成锡复合物的锡离子源和多磷酸盐、二氧化硅磨料等,但仍可具有至少5000ppm,至少10000ppm或至少20000ppm的平均锡离子摄取。如本文所述的口腔护理组合物在不同的非织造纤维网层中、在单独的部分中、在口腔护理组合物的单独的组合物中或在可溶性固相中在物理上将金属离子源与多磷酸盐、二氧化硅磨料或其他螯合剂分离。这些组分的物理分离先前一直是难以实现的。单位剂量口腔护理组合物(诸如小袋、固体泡沫或可溶性纤维组合物)提供基础结构,该基础结构可在储存期间在物理上将金属离子与其他反应性组分分离,但也允许它们能够在口腔中溶解和/或崩解时组合。
形态
如本文所述,口腔护理组合物可由其形态来描述,其相对于其他口腔护理组合物诸如洁齿剂糊剂和/或漱口液是独特的。例如,包含纤维组合物的单位剂量口腔护理组合物可以是纤维和/或长丝的非织造纤维网。包含固体可溶性泡沫组合物的单位剂量口腔护理组合物可在由撑条连接的固体泡沫网络内具有空隙。固体可溶性泡沫组合物可具有至少约75%,至少约85%或至少约88%的平均空隙体积百分比,或空隙空间与泡沫占据的总空间之间的比率。相比之下,纤维组合物可具有约15%至约75%,约15%至约70%,约30%至约75%或约35%至约70%的平均空隙体积。洁齿剂糊剂和/或漱口液在被消费者使用之前将具有小于15%的平均空隙体积百分比。
固体可溶性泡沫组合物可具有大于约0.1mm,大于约0.2mm或大于约0.3mm的平均孔径。相比之下,纤维组合物可具有约0.001mm至约0.1mm,约0.01mm至约0.05mm或约0.01mm至约0.1mm的平均孔径。由于洁齿剂糊剂和/或漱口液是液体和/或糊剂,因此预计洁齿剂糊剂和/或漱口液在被消费者使用前将不具有孔。
固体可溶性泡沫组合物可具有约50mm-1至约150mm-1,约75mm-1至约160mm-1或约100mm-1至约150mm-1的表面积。相比之下,纤维组合物的表面可为至少约150mm-1,至少约200mm-1或至少约250mm-1。
实施例
以下实施例进一步描述并展示了本发明范围内的实施方案。这些实施例仅为了例证目的而给出并且不可被理解为是对本发明的限制,因为在不脱离本发明的实质和范围的情况下可能有许多变型。除非另外指明,否则所有示例的量均为按总组合物的重量计的浓度,即,wt/wt百分比。
单位剂量口腔护理组合物
纤维单位剂量口腔护理组合物由纤维组合物和非纤维组合物组合而成。基于表1,通过首先将USP水加入到分批混合槽中来制备纤维组合物。水的目标量为60重量%,包括与任何含水组分一起引入的水,因此所加入的组分的实际量基于批尺寸和目标组合物而变化。接着,将目标量的木糖醇加入分批混合槽中,同时以60rpm混合。将目标量的聚乙烯醇加入分批混合槽中。将分批混合槽加热至80℃。将混合物在80℃下加热并以120rpm搅拌2小时。
将目标量的月桂基硫酸钠和椰油酰胺基丙基甜菜碱作为水溶液依次加入。接着,将三氯蔗糖加入混合物中。最后,如果需要,加入氟离子源。允许纤维组合物熔体在70℃下搅拌的同时在夜间脱气。
允许纤维组合物熔体冷却至40℃,并且将纤维组合物熔体纺丝成长丝和/或纤维。将纤维组合物熔体从间分批混合槽转移至纤维纺丝模具。纤维和/或长丝经由Biax-fiberfilm多排毛细管模具在60℃下挤出。将纤维和/或长丝拉细并用热空气干燥,使其具有小于5%的水分。在带上收集纤维和/或长丝作为纤维组合物。
通过将表1中列出的组分添加到PEG-12中,利用机械混合产生浆液来合成非纤维组合物。
通过将第一条纤维组合物置于模板上来组合纤维单位剂量组合物。通过在每个模孔内施加力来制备纤维组合物中的空腔。用点滴器将非纤维组合物施加到空腔内部。将第二条纤维组合物置于模板顶部。施加压力以切割并粘结第一和第二纤维组合物层的边缘。从模切机中去除剂量,并且对于每个剂量重复该过程。
表1.单位剂量口腔护理组合物
1粉末
2PVA403和PVA420H的混合物
HAP溶解
HAP溶解方法被设计成测试所选测试洁齿剂的酸保护作用。在用测试洁齿剂浆液处理羟基磷灰石粉末(HAP)后,将HAP加入到酸性介质中,并且pH的变化为表面吸附程度的指标。pH升高越小,表面保护作用越好。
针对表2中所列的比较处理组合物,制备洁齿剂浆液(1:3糊剂:水)。具体地讲,在具有搅拌棒的50mL容器中,将10g洁齿剂糊剂与30g去离子水混合。将该容器置于搅拌板上混拌,直到两种组分混合。将糊料浆液以15,000rpm离心15min。
对于每个处理,包括水对照,将0.300g羟基磷灰石粉末(HAP)置于50mL圆底离心管中。对于用洁齿剂糊剂处理,将24mL制得的洁齿剂浆液加入到HAP中。对于用实施例1-4处理,将24mL水和8单位剂量的实施例1-4加入到HAP中。将每个经处理的HAP样品以2500rpm立即涡旋混合2分钟。然后将所有样品以15,000rpm离心15分钟。将液相滗出离心管,这留下HAP粒料。通过以下步骤将剩余的HAP粒料冲洗三次:加入去离子水,以2500rpm涡旋混合1分钟,以15,000rpm离心15分钟,以及将液相滗出离心管。将经处理的HAP粒料在55℃烘箱中干燥过夜。
然后分析HAP样品的氟离子摄取。将0.100g经干燥和处理的HAP置于50mL Falco管中。将25mL 0.5M高氯酸加入到每个Falco管中,并且将每个样品以2500rpm涡旋混合1分钟。将每个经消化的样品的1mL等分试样加入到塑料小瓶中。将1mL经pH调节的TISAB II(6:1TISAB II:2N NaOH)加入到每个样品中。经由氟离子选择性电极(Beckman Coulter,Inc.,Pasadena,CA,目录号A51712)测量氟含量。
分析HAP样品的ΔpH。将25mL 10mM柠檬酸(1L去离子水中1.9212g柠檬酸)加入到具有搅拌棒的50mL烧杯中。将该烧杯置于搅拌板(Metrohm,Herisau,Switerland,型号728)上并开启。将Titrano pH电极(Metrohm,Herisau,Switzerland,型号719S)置于含有柠檬酸的搅拌烧杯中。在柠檬酸溶液平衡后(直至pH在30秒内具有2.5±0.001pH的最小变化),将50mg经干燥的HAP粉末加入到柠檬酸溶液中。在5分钟和10分钟时记录pH。由下式I来确定功效%。
通过将0.100g经干燥和处理的HAP与25mL 90:10(HNO3:HBF3)消化剂混合来分析HAP样品的锡离子摄取。经由ICP-MS通过与锡离子的标准浓度曲线的值进行比较来分析经消化的HAP粉末的等分试样的总锡离子摄取。
表2.通过HAP溶解获得的平均F和Sn摄取
表2示出了通过本文所述的HAP溶解获得的平均Sn和F摄取。经水或CCP处理的HAP样品的平均Sn摄取导致平均Sn摄取<500ppm。这是预计的结果,因为水或CCP均不包含添加的锡离子,诸如SnF2。水显示平均F摄取为136ppm,而CCP(0.243重量%NaF)显示平均F摄取为2286ppm。CPH(0.454重量%SnF2和六偏磷酸钠)显示平均Sn摄取为4987ppm且平均F摄取为1038ppm。CPH相对于CCP的功效%为17.2%,这表明在HAP粉末上CPH的表面保护比CCP高17.2%。因此,相对于CCP将F沉积在HAP粉末上,CPH负责将Sn、F和六偏磷酸钠沉积在HAP粉末上。
实施例1在纤维组合物中具有SnF2,并且在非纤维组合物中具有六偏磷酸钠。尽管被配制成理论上计算量的氟离子(以及相关地亚锡离子),但实施例1具有34100ppm(几乎7倍)的平均Sn摄取和2182ppm(2倍)的平均F摄取。另外,实施例1的相对于CCP的功效%为47.3%(为CPH的3倍)。
如表2所示,实施例2与实施例1相同(SnF2处于纤维组合物中且六偏磷酸钠处于非纤维组合物中),但是实施例2不包含螯合剂葡萄糖酸钠。实施例1在纤维组合物中具有葡萄糖酸钠,该葡萄糖酸钠用于与锡离子弱缔合以防止与其它洁齿剂组分诸如水溶液中的六偏磷酸钠不可逆地结合。实施例2具有25800ppm的平均Sn摄取(为CPH的5倍)和2401ppm的平均F摄取(为CPH的2倍)。另外,实施例1的相对于CCP的功效%为36.6%(为CPH的2倍)。虽然实施例2导致比CPH更多的表面吸收,但是实施例2的性能略差于实施例1。因此,虽然可使用螯合剂来改善Sn摄取和总吸收,但是要优于CPH无需添加螯合剂诸如葡糖酸盐。
如表2所示,实施例3类似于实施例1的组合物,但是SnF2和葡萄糖酸钠被置于具有六偏磷酸钠的非纤维组合物中。这些化合物处于固相中(即,未溶解或分散于溶剂中),直到碰到含水处理溶液,从而有效地模拟单位剂量洁齿剂在口腔中的使用。实施例3优于实施例2和CPH,但是未达到如实施例1的功效%或Sn摄取,其中多磷酸盐和SnF2储存于分离相中。实施例4类似于实施例3,不同的是不含葡萄糖酸钠螯合剂。如所预计的,与实施例3相比,去除螯合剂导致稍差的性能,但是相对于可商购获得的洁齿剂组合物诸如CPH或CCP,仍具有优异的性能。
实施例5在纤维组合物中具有NaF,并且在非纤维组合物中具有CaCl2。尽管被配制成提供相同数目的总F离子,但平均F摄取为5765ppm,这显著高于具有2286ppm的平均F摄取的对应糊剂洁齿剂CCP。因此,实施例5具有显著更高量的生物可利用的F离子,或由于与其它组分的反应性而未被绑占的F离子。
在分析期间,氟摄取的一些增加可能是由于F吸附在HAP表面上而发生的,而一些可能是由于在离心期间被回收的CaF2的形成而发生的。这与以下观察结果一致:一些颗粒未完全润湿,表明形成了新的颗粒。在口腔中,CaF2在溶解时的瞬时形成可在数分钟至数小时期间内增加氟的保留和可用性,因为沉积的CaF2可与HAP缓慢相互作用。
虽然通常预计Ca和F将在沉积于口腔中之前反应,但是在物理上将Ca(处于非纤维组合物中)与F(处于纤维组合物中)分离出乎意料地导致优异的平均F摄取和在HAP表面上观察到CaF2沉积(相对于吸附)。不受理论的束缚,如果将Ca配制于纤维组合物中并且将氟离子源配制于非纤维组合物中,如果这两种离子均作为固体颗粒(即,未至少部分地溶解于溶剂中)存在于同一组合物中诸如在非纤维组合物中或溶解于加入到非纤维组合物中的低水(<25%水)溶剂中,预计出现相同的结果。
釉质氟摄取
FDA方法40的釉质氟摄取是用于测定递送至脱矿质釉质样本的氟量的方法,所述脱矿质釉质样本来自1:3洁齿剂浆液的单一30分钟处理。
从整个人牙齿提取直径为3-4mm的优质人釉质的芯。将芯安装在亚克力棒上,并且使用600号粒度磨削表面。然后用0.05μ抛光剂(氧化铝悬浮液γB,MetLab Corp,目录号M303-128)抛光芯。将样本储存在标准实验室冰箱(约2-4℃)中少量去离子水(约1-5mL)上方气密容器中。
检查每个釉质样本,并且丢弃具有大裂纹或不均匀钙化的样品。使用0.05μ抛光剂将样本再次抛光10分钟。用超声波破碎仪将样品在去离子水中超声处理15-30分钟。然后用标准去离子水冲洗釉质样本,并且擦拭以去除任何残余抛光剂。
然后将釉质样本脱矿质。对于每个样本,将25mL的MHDP(N-2-羟乙基,甲烷羟基二膦酸盐)脱矿质溶液(0.025M乳酸,2×10-4MMHDP)置于30mL塑料小瓶中。将釉质样本置于每个小瓶的盖上。将每个盖置于小瓶顶部以将釉质样本浸没在MHDP脱矿质溶液中。不允许釉质样本接触小瓶的底部。在环境条件下使样本在脱矿质溶液中保留48小时以形成人造龋齿损害。每天轻敲棒两次以去除任何气泡。48小时后,将样本从脱矿质溶液中取出,并且用去离子水充分冲洗。
如果样品为糊剂洁齿剂,则将10g洁齿剂置于50mL的三角可倾倒塑料烧杯中。将30mL去离子水加入到烧杯中。将x形搅拌棒置于每个烧杯中洁齿剂顶部上,并且将烧杯置于磁力搅拌板上。用木棍打碎洁齿剂,直至搅拌棒能够以300-400rpm自由旋转。将洁齿剂浆液搅拌20分钟。将浆液转移到离心管中并以11,000rpm离心30分钟。
如果样品为固体洁齿剂,则称量10剂量的固体形式洁齿剂并置于50mL的三角可倾倒塑料烧杯中。加入去离子水以使混合的水和样品质量达到10g。然后将30mL另外的去离子水放入烧杯中。将x形搅拌棒置于每个烧杯中洁齿剂顶部上,并且将烧杯置于磁力搅拌板上。将浆液以300-400rpm混合20分钟。将浆液转移到离心管中并以11,000rpm离心30分钟。
将浆液上清液(对于固体和糊剂形式)滗析到50mL的三角可倾倒塑料烧杯中。将x形搅拌棒置于烧杯中,并且将烧杯置于磁力搅拌板上。将搅拌板调至300-400rpm。将病变的釉质样本悬浮到每个处理中。将每个样品处理30分钟。30分钟后,用去离子水冲洗每个样品。将样品储存在标准实验室冰箱(约2-4℃)中少量去离子水(约1-5mL)上方气密容器中。
通过在钻孔后收集经碾磨的釉质粉末,并且将釉质溶解于酸中,然后将其中和并缓冲,来分析样品的氟含量分析。在从釉质样本钻出样品时,记录钻出的釉质面积。
使用氟离子特异性电极(Thermo Scientific,Orion,96-09-00,Waltham,MA)直接测量氟摄取。将每个样本样品置于电极的端部上。记录mV值。通过使用所准备的氟化物标准物的标准曲线,将该值转化成ppm氟。氟摄取通过将以μg计的氟质量除以用微钻活检取样的总面积来计算。
釉质氟摄取方法基于FDA测试方法#40。釉质氟摄取结果提供于表4中。
平均释放氟
使用去离子水稀释氟化物原液(0.5mg/mL,500ppm,Ricca,RC3172-16,Arlington,TX)以制备25ppm、50ppm和250ppm的溶液。将每个标准物用TISAB II(Ricca,RC867016,Arlington,TX)缓冲溶液以1:1比率稀释以形成校准溶液。
使用校准溶液创建校准曲线。将200μL的25ppm校准溶液置于微样品杯中。将氟电极置于溶液中,并记录每个样品的mV。对每个所准备的校准溶液重复该规程。通过以mV相对于Log[F-]绘图来构建校准曲线。
通过在70mL高速混合器杯中称量大约4g的每个糊剂样品来准备糊剂洁齿剂样品。通过称量4剂量的每个洁齿剂样品并以4g加入适量去离子水来准备固体洁齿剂样品。接下来,将12mL去离子水加入到样品杯中。使用Speedmixer Program#7使高速混合器杯混合60秒(FlackTek Speedmixer,Landrum,SC),此为以800rpm混合5秒,然后以2200rpm混合55秒。将浆液样品转移到离心管中,然后以11,000rpm离心10分钟。
通过将1mL上清液和1mL新鲜TISAB II缓冲液混合来准备用于分析的样品。使用涡旋混合器将该样品快速混合。将200μL溶液转移到微样品杯中。将氟电极置于盖中。记录值(mV)。
使用下文提供的式1来计算释放的氟的值。
[F]=样品上清液的氟浓度(ppm)
稀释因子:
NaF和SnF2=4-(式%不溶性原料/100)
*不溶性原料(IRM)包括二氧化硅、二氧化钛、云母和球粒。
表3.测试的组合物
1PVA403和PVA420H的混合物
表4.平均氟摄取
处理 | 制剂氟含量(ppm) | 平均氟摄取(μg F/cm2) |
NaF USPa | 1100 | 8.45 |
SnF2 USPb | 1100 | 10.00 |
实施例6 | 1100 | 9.32 |
实施例7 | 1100 | 23.33c |
实施例8 | 1100 | 8.76 |
实施例9 | 1100 | 5.27 |
aUSP水中氟化钠标准物
bUSP水中氟化亚锡标准物
c两个处理方案的平均值
表4示出了根据如本文所述的FDA方法#40,实施例6-9与NaF USP标准物和SnF USP标准物相比的平均氟摄取。实施例6-9被配制成理论上提供1100ppm的氟。实施例6(NaF)具有9.32μg F/cm2的平均氟摄取,而Na USP标准物具有8.45μg F/cm2的平均氟摄取。因此,将氟化物与牙膏的其它反应性组分分离的单位剂量口腔护理组合物,如本文所述并且由实施例6所示,优于NaF USP标准物。
此外,实施例7(SnF2)具有23.33μg F/cm2的平均氟摄取,而SnF2 USP标准物具有10.00μg F/cm2的平均摄取。实施例7的平均氟摄取是如此出乎意料地高以至于进行第二次运行以确认结果。因此,将氟化物与牙膏的其它反应性组分分离的单位剂量口腔护理组合物,如本文所述并且由实施例7所示,优于SnF2 USP标准物。
表5:1分钟氟释放
表5示出了表3的单位剂量口腔护理组合物的1分钟氟释放。实施例6(NaF)和实施例7(SnF2)在接触水1分钟内释放96.5%和99.0%的其氟离子。相比之下,洁齿剂组合物诸如Cavity Protection和SnF2 USP在1分钟内仅分别释放91.3%和72.4%的氟离子。因此,通过在1分钟内释放生物可利用的氟离子,实施例6和7的单位剂量口腔护理组合物可优于常规洁齿剂组合物。不受理论的束缚,氟离子的快速释放可为有利的,因为使用洁齿剂组合物来提供氟的个体可能不总是用洁齿剂组合物刷洗足够长的时间以接收洁齿剂组合物的全部有益效果。
除非明确排除或以其它方式限制,本文中引用的每一篇文献,包括任何交叉引用或相关专利或专利申请以及本申请对其要求优先权或其有益效果的任何专利申请或专利,均据此全文以引用方式并入本文。对任何文献的引用不是对其作为与本发明的任何所公开或本文受权利要求书保护的现有技术的认可,或不是对其自身或与任何一个或多个参考文献的组合提出、建议或公开任何此类发明的认可。此外,当本发明中术语的任何含义或定义与以引用方式并入的文献中相同术语的任何含义或定义矛盾时,应当服从在本发明中赋予该术语的含义或定义。
虽然已举例说明和描述了本发明的具体实施方案,但是对于本领域技术人员来说显而易见的是,在不脱离本发明的实质和范围的情况下可作出多个其它变化和修改。因此,本文旨在于所附权利要求中涵盖属于本发明范围内的所有此类变化和修改。
Claims (27)
1.一种单位剂量口腔护理组合物,包含:
(a)由一种或多种纤维网形成材料形成的纤维组合物,其中所述一种或多种纤维网形成材料包括聚乙烯醇;
(b)氟离子源;以及
(c)磨料,
其中所述口腔护理组合物还包含按所述组合物的重量计0.01%至40%的钙离子源,并且所述钙离子源和所述氟离子源是物理分离的或者处于不同相中。
2.根据权利要求1所述的单位剂量口腔护理组合物,其中所述组合物还包含按所述组合物的重量计0.01%至10%的金属离子源。
3.根据权利要求2所述的单位剂量口腔护理组合物,其中所述金属离子源包括锡离子源、锌离子源、或它们的组合。
4.根据权利要求1至3中任一项所述的单位剂量口腔护理组合物,其中所述口腔护理组合物具有按所述组合物的重量计0.01%至10%的所述氟离子源。
5.根据权利要求1至3中任一项所述的单位剂量口腔护理组合物,其中所述钙离子源包括钙磨料、钙盐、或它们的组合。
6.根据权利要求1至3中任一项所述的单位剂量口腔护理组合物,其中所述口腔护理组合物具有至少1000ppm或至少2000ppm的平均氟摄取。
7.根据权利要求1至3中任一项所述的单位剂量口腔护理组合物,其中所述单位剂量口腔护理组合物包含1%至50%的所述一种或多种纤维网形成材料。
8.根据权利要求1至3中任一项所述的单位剂量口腔护理组合物,其中所述氟离子源包括氟化钠、单氟磷酸钠、氟化亚锡、氟化胺、或它们的组合。
9.根据权利要求1至3中任一项所述的单位剂量口腔护理组合物,其中所述口腔护理组合物包含按所述组合物的重量计0.01%至小于10%的所述一种或多种纤维网形成材料。
10.一种口腔护理组合物,包含:
(a)一种或多种纤维网形成材料,其中所述一种或多种纤维网形成材料包括聚乙烯醇;
(b)按所述口腔护理组合物的重量计0.01%至40%的钙离子源;以及
(c)氟离子源,其中所述口腔护理组合物具有至少1000ppm的平均氟摄取;
其中所述钙离子源和所述氟离子源是物理分离的或者处于不同相中。
11.根据权利要求10所述的口腔护理组合物,其中所述钙离子源为钙盐,并且所述口腔护理组合物还包含磨料。
12.根据权利要求10或11所述的口腔护理组合物,其中所述口腔护理组合物包含按所述口腔护理组合物的重量计1%至50%的所述一种或多种纤维网形成材料。
13.根据权利要求10所述的口腔护理组合物,其中所述钙离子源包括钙磨料、钙盐、或它们的组合。
14.根据权利要求10或11所述的口腔护理组合物,其中所述氟离子源包括氟化钠、单氟磷酸钠、氟化亚锡、氟化胺、或它们的组合。
15.根据权利要求10或11所述的口腔护理组合物,其中所述口腔护理组合物包含按所述口腔护理组合物的重量计0.01%至10%的所述氟离子源。
16.一种口腔护理组合物,包含:
(a)一个或多个非织造纤维网层,所述一个或多个非织造纤维网层包含:
(i)一种或多种纤维网形成材料,其中所述一种或多种纤维网形成材料包括聚乙烯醇,以及(ii)氟离子源;
(b)非纤维组合物,所述非纤维组合物包含钙离子源,其中所述口腔护理组合物包含按所述口腔护理组合物的重量计0.01%至40%的所述钙离子源,
其中所述钙离子源和所述氟离子源是物理分离的或者处于不同相中。
17.根据权利要求16所述的口腔护理组合物,其中所述口腔护理组合物包含按所述口腔护理组合物的重量计0.01%至10%的所述氟离子源。
18.根据权利要求16所述的口腔护理组合物,其中所述氟离子源包括氟化钠、单氟磷酸钠、氟化亚锡、氟化胺、或它们的组合。
19.根据权利要求16所述的口腔护理组合物,其中所述钙离子源包括钙磨料、钙盐、或它们的组合。
20.根据权利要求16所述的口腔护理组合物,其中所述口腔护理组合物具有至少1000ppm的平均氟摄取。
21.根据权利要求16所述的口腔护理组合物,其中所述口腔护理组合物包含按所述口腔护理组合物的重量计0.01%至小于10%的所述一种或多种纤维网形成材料。
22.一种口腔护理组合物,包含:
(a)一个或多个非织造纤维网层,所述一个或多个非织造纤维网层包含:
(i)一种或多种纤维网形成材料,其中所述一种或多种纤维网形成材料包括聚乙烯醇,以及(ii)钙离子源,其中所述口腔护理组合物包含按所述口腔护理组合物的重量计0.01%至40%的所述钙离子源;
(b)非纤维组合物,所述非纤维组合物包含氟离子源,其中所述钙离子源和所述氟离子源是物理分离的或者处于不同相中。
23.根据权利要求22所述的口腔护理组合物,其中所述钙离子源包括钙磨料、钙盐、或它们的组合。
24.根据权利要求22所述的口腔护理组合物,其中所述口腔护理组合物包含按所述口腔护理组合物的重量计0.01%至10%的所述氟离子源。
25.根据权利要求22所述的口腔护理组合物,其中所述氟离子源包括氟化钠、单氟磷酸钠、氟化亚锡、氟化胺、或它们的组合。
26.根据权利要求22所述的口腔护理组合物,其中所述口腔护理组合物具有至少1000ppm的平均氟摄取。
27.根据权利要求22所述的口腔护理组合物,其中所述口腔护理组合物包含按所述口腔护理组合物的重量计0.01%至小于10%的所述一种或多种纤维网形成材料。
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862671083P | 2018-05-14 | 2018-05-14 | |
US201862671066P | 2018-05-14 | 2018-05-14 | |
US201862671078P | 2018-05-14 | 2018-05-14 | |
US201862671072P | 2018-05-14 | 2018-05-14 | |
US62/671078 | 2018-05-14 | ||
US62/671083 | 2018-05-14 | ||
US62/671072 | 2018-05-14 | ||
US62/671066 | 2018-05-14 | ||
PCT/US2019/032126 WO2019222153A1 (en) | 2018-05-14 | 2019-05-14 | Oral care compositions comprising fluoride ions |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112118823A CN112118823A (zh) | 2020-12-22 |
CN112118823B true CN112118823B (zh) | 2023-07-28 |
Family
ID=68463724
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201980032233.0A Active CN112135668B (zh) | 2018-05-14 | 2019-05-14 | 包含金属离子的口腔护理组合物 |
CN201980032394.XA Active CN112135600B (zh) | 2018-05-14 | 2019-05-14 | 发泡口腔护理组合物 |
CN201980032399.2A Pending CN112118893A (zh) | 2018-05-14 | 2019-05-14 | 单位剂量口腔护理组合物 |
CN201980032396.9A Active CN112118823B (zh) | 2018-05-14 | 2019-05-14 | 包含氟离子的口腔护理组合物 |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201980032233.0A Active CN112135668B (zh) | 2018-05-14 | 2019-05-14 | 包含金属离子的口腔护理组合物 |
CN201980032394.XA Active CN112135600B (zh) | 2018-05-14 | 2019-05-14 | 发泡口腔护理组合物 |
CN201980032399.2A Pending CN112118893A (zh) | 2018-05-14 | 2019-05-14 | 单位剂量口腔护理组合物 |
Country Status (9)
Country | Link |
---|---|
US (10) | US10835455B2 (zh) |
EP (4) | EP3793515A1 (zh) |
JP (7) | JP7112520B2 (zh) |
CN (4) | CN112135668B (zh) |
AU (6) | AU2019269408B9 (zh) |
BR (2) | BR112020023002A2 (zh) |
CA (4) | CA3100060C (zh) |
MX (4) | MX385757B (zh) |
WO (4) | WO2019222153A1 (zh) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112013000044B1 (pt) | 2010-07-02 | 2022-01-04 | The Procter & Gamble Company | Método para a distribuição de agentes ativos a artigos de tecido ou superfícies duras |
CN103003476B (zh) | 2010-07-02 | 2016-02-10 | 宝洁公司 | 纤维网材料以及用于制造纤维网材料的方法 |
WO2012003319A2 (en) | 2010-07-02 | 2012-01-05 | The Procter & Gamble Company | Filaments comprising an active agent nonwoven webs and methods for making same |
US20180163325A1 (en) * | 2016-12-09 | 2018-06-14 | Robert Wayne Glenn, Jr. | Dissolvable fibrous web structure article comprising active agents |
US12318406B2 (en) * | 2013-03-15 | 2025-06-03 | Cda Research Group, Inc. | Methods of treatment using topical copper ion formulations |
US11318089B2 (en) | 2013-03-15 | 2022-05-03 | Cda Research Group, Inc. | Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body |
US10398733B2 (en) | 2013-03-15 | 2019-09-03 | Cda Research Group, Inc. | Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body |
US11000545B2 (en) | 2013-03-15 | 2021-05-11 | Cda Research Group, Inc. | Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza |
MX380727B (es) | 2017-01-27 | 2025-03-12 | Procter & Gamble | Composiciones en la forma de estructuras sólidas solubles que comprenden partículas aglomeradas efervescentes. |
EP3624765A1 (en) | 2017-05-16 | 2020-03-25 | The Procter and Gamble Company | Conditioning hair care compositions in the form of dissolvable solid structures |
US11911492B2 (en) | 2018-05-14 | 2024-02-27 | The Procter & Gamble Company | Oral care compositions comprising metal ions |
US10835455B2 (en) | 2018-05-14 | 2020-11-17 | The Procter & Gamble Company | Oral care compositions comprising metal ions |
US11666514B2 (en) | 2018-09-21 | 2023-06-06 | The Procter & Gamble Company | Fibrous structures containing polymer matrix particles with perfume ingredients |
US10918584B2 (en) | 2018-12-26 | 2021-02-16 | Colgate-Palmolive Company | Oral care compositions and methods for the same |
EP3980962A1 (en) | 2019-06-10 | 2022-04-13 | The Procter & Gamble Company | Method of generating user feedback information to enhance product use results |
BR112021024255A2 (pt) | 2019-06-13 | 2022-01-11 | Procter & Gamble | Kits compreendendo composições para tratamento bucal de dose unitária |
WO2020264574A1 (en) | 2019-06-28 | 2020-12-30 | The Procter & Gamble Company | Dissolvable solid fibrous articles containing anionic surfactants |
US20220362140A1 (en) * | 2020-01-29 | 2022-11-17 | Group Pharmaceuticals | Novel Dental Care and Cleansing Composition |
WO2021168696A1 (en) | 2020-02-26 | 2021-09-02 | The Procter & Gamble Company | Oral care compositions for gum health |
WO2021168684A1 (en) | 2020-02-26 | 2021-09-02 | The Procter & Gamble Company | Oral care compositions for gum health |
US12138328B2 (en) | 2020-04-10 | 2024-11-12 | The Procter & Gamble Company | Rheological solid composition |
US12138333B2 (en) | 2020-04-10 | 2024-11-12 | The Procter & Gamble Company | Rheological solid composition for use in personal care compositions |
US12122979B2 (en) | 2020-04-10 | 2024-10-22 | The Procter & Gamble Company | Cleaning article with preferential rheological solid composition |
CN115335499A (zh) | 2020-04-10 | 2022-11-11 | 宝洁公司 | 具有流变固体组合物的清洁工具 |
BR112022022405A2 (pt) | 2020-05-05 | 2022-12-13 | Procter & Gamble | Composições para tratamento bucal compreendendo ácido dicarboxílico |
WO2021226154A1 (en) | 2020-05-05 | 2021-11-11 | The Procter & Gamble Company | Oral care compositions comprising dicarboxylic acid |
JP2023523310A (ja) | 2020-05-05 | 2023-06-02 | ザ プロクター アンド ギャンブル カンパニー | ジカルボン酸を含む口腔ケア組成物 |
MX2022013042A (es) | 2020-05-05 | 2022-11-09 | Procter & Gamble | Composiciones para el cuidado bucal que comprenden estaño. |
WO2021226157A1 (en) | 2020-05-05 | 2021-11-11 | The Procter & Gamble Company | Remineralizing oral care compositions comprising tin |
US20210346252A1 (en) | 2020-05-05 | 2021-11-11 | The Procter & Gamble Company | Remineralizing Oral Care Compositions Comprising Tin |
MX2022013040A (es) | 2020-05-05 | 2022-11-09 | Procter & Gamble | Composiciones para el cuidado bucal que comprenden ligando monodentado y polidentado. |
JP7506249B2 (ja) | 2020-07-31 | 2024-06-25 | ザ プロクター アンド ギャンブル カンパニー | ヘアケア用プリル含有水溶性繊維パウチ |
EP4284326A1 (en) | 2021-02-01 | 2023-12-06 | The Procter & Gamble Company | Oral care composition comprising oxalic acid |
AU2022214550B2 (en) | 2021-02-01 | 2025-04-17 | The Procter & Gamble Company | Oral composition comprising oxalic acid |
US11833237B2 (en) | 2021-03-09 | 2023-12-05 | The Procter & Gamble Company | Method for enhancing scalp active deposition |
AU2022246246A1 (en) | 2021-03-25 | 2023-09-14 | The Procter & Gamble Company | Edible oral compositions comprising hops |
CN113069374A (zh) * | 2021-04-10 | 2021-07-06 | 江西师范大学 | 一种含有机过氧化物的美白牙粉及其制备方法 |
US20220339082A1 (en) * | 2021-04-23 | 2022-10-27 | Colgate-Palmolive Company | Solid Oral Care Compositions |
CA3219441A1 (en) | 2021-05-11 | 2022-11-17 | The Procter & Gamble Company | Oral care compositions comprising block copolymer |
EP4392010A1 (en) | 2021-08-23 | 2024-07-03 | The Procter & Gamble Company | Oral care compositions for gum health |
WO2023023884A1 (en) | 2021-08-23 | 2023-03-02 | The Procter & Gamble Company | Oral care compositions for gum health |
US20230133630A1 (en) | 2021-11-04 | 2023-05-04 | The Procter & Gamble Company | Oral Care Compositions Comprising Dicarboxylic Acid |
WO2023133368A1 (en) | 2022-01-04 | 2023-07-13 | The Procter & Gamble Company | Oral care based digital imaging systems and methods for evaluating an oral care product |
MX2024011600A (es) * | 2022-04-04 | 2024-09-30 | Procter & Gamble | Composiciones de dosis unitaria para el cuidado bucal que comprenden fluoruro. |
WO2023196214A1 (en) * | 2022-04-04 | 2023-10-12 | The Procter & Gamble Company | Unit-dose oral care compositions comprising fluoride |
US20250009619A1 (en) | 2023-06-28 | 2025-01-09 | The Procter & Gamble Company | Oral Care Compositions Comprising Hops Beta Acids And Tin |
US20250009641A1 (en) | 2023-06-28 | 2025-01-09 | The Procter & Gamble Company | Oral Care Compositions Comprising Hops Beta Acids |
WO2025000250A1 (en) | 2023-06-28 | 2025-01-02 | The Procter & Gamble Company | Oral care compositions comprising hops beta acids |
WO2025059393A1 (en) | 2023-09-14 | 2025-03-20 | The Procter & Gamble Company | Dispensing an oral care composition with improved flavor display |
WO2025059396A1 (en) | 2023-09-14 | 2025-03-20 | The Procter & Gamble Company | Oral care compositions comprising hops beta acids and tin |
WO2025080747A1 (en) | 2023-10-11 | 2025-04-17 | The Procter & Gamble Company | Oral care compositions comprising dicarboxylic acid |
WO2025080746A1 (en) | 2023-10-11 | 2025-04-17 | The Procter & Gamble Company | Oral care compositions comprising dicarboxylic acid |
US20250120897A1 (en) | 2023-10-11 | 2025-04-17 | The Procter & Gamble Company | Oral care compositions comprising dicarboxylic acid |
WO2025080744A1 (en) | 2023-10-11 | 2025-04-17 | The Procter & Gamble Company | Oral care compositions comprising dicarboxylic acid |
WO2025080741A1 (en) | 2023-10-11 | 2025-04-17 | The Procter & Gamble Company | Oral care compositions comprising dicarboxylic acid |
WO2025076709A1 (en) | 2023-10-11 | 2025-04-17 | The Procter & Gamble Company | Oral care compositions comprising dicarboxylic acid |
WO2025101681A1 (en) | 2023-11-09 | 2025-05-15 | The Procter & Gamble Company | Intraoral device, system, and method for oral care based digital imaging |
GB2636062A (en) * | 2023-11-10 | 2025-06-11 | Lintbells Ltd | Dental paste |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1713886A (zh) * | 2002-11-26 | 2005-12-28 | 宝洁公司 | 可咀嚼的固体单位剂型和可用于将活性剂递送到牙齿咬合面的方法 |
CN103282015A (zh) * | 2010-07-02 | 2013-09-04 | 宝洁公司 | 包含活性剂的可溶性纤维网结构制品 |
CN104069013A (zh) * | 2006-10-02 | 2014-10-01 | 宝洁公司 | 亚锡口腔护理组合物 |
Family Cites Families (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3678154A (en) | 1968-07-01 | 1972-07-18 | Procter & Gamble | Oral compositions for calculus retardation |
US3535421A (en) | 1968-07-11 | 1970-10-20 | Procter & Gamble | Oral compositions for calculus retardation |
US3964166A (en) | 1974-10-21 | 1976-06-22 | Mynol, Inc. | Dental prophylaxis implement |
US4157386A (en) * | 1978-05-18 | 1979-06-05 | Rochelle Paul J | Soft, chewable lozenge forming a sticky coating on teeth when combined with saliva in the mouth which is removable only by brushing |
JPS5846483B2 (ja) * | 1979-09-20 | 1983-10-17 | ライオン株式会社 | 口腔用組成物 |
US4267164A (en) * | 1980-01-31 | 1981-05-12 | Block Drug Company Inc. | Effervescent stannous fluoride tablet |
US4765984A (en) | 1986-01-22 | 1988-08-23 | Colgate-Palmolive Company | Stable single unit dose oral product |
US5180577A (en) | 1990-10-09 | 1993-01-19 | Colgate-Palmolive | Stabilized bis biguanide/anionic active ingredient compositions |
DE19646392A1 (de) | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht |
US6713049B1 (en) | 1999-11-12 | 2004-03-30 | The Procter & Gamble Company | Oral compositions providing optimal surface conditioning |
AU5725798A (en) * | 1997-12-29 | 1999-07-19 | Procter & Gamble Company, The | Tooth cleaning composition in tablet form |
NL1009030C1 (nl) * | 1998-04-29 | 1999-11-01 | Antonius Jozef Maria Manders | Tandpasta en werkwijze voor het reinigen van tanden. |
US20020068038A1 (en) | 1998-12-05 | 2002-06-06 | Joo Hwan Yang | Foaming tablet for cleaning the oral cavity and preparation method thereof |
US6685920B2 (en) | 1999-11-12 | 2004-02-03 | The Procter & Gamble Company | Method of protecting teeth against erosion |
CA2389174C (en) | 1999-11-12 | 2007-01-23 | The Procter & Gamble Company | Improved stannous oral compositions |
US20040146466A1 (en) | 1999-11-12 | 2004-07-29 | The Procter & Gamble Company | Method of protecting teeth against erosion |
US20070025928A1 (en) * | 1999-11-12 | 2007-02-01 | The Procter & Gamble Company | Stannous oral care compositions |
CA2387956C (en) | 1999-11-12 | 2007-02-06 | The Procter & Gamble Company | Improved dual phase stannous oral compositions |
US7387774B2 (en) | 1999-11-12 | 2008-06-17 | The Procter & Gamble Co. | Method of enhancing fluoridation and mineralization of teeth |
GB0115227D0 (en) | 2001-03-22 | 2001-08-15 | Electrosols Ltd | Manufacturing dissolvable dosage forms |
WO2003030851A1 (fr) * | 2001-10-01 | 2003-04-17 | Lion Corporation | Procede, composition et ensemble de blanchiment des dents |
US20060039958A1 (en) * | 2003-05-28 | 2006-02-23 | Monosolrx, Llc. | Multi-layer films having uniform content |
ES2346856T3 (es) | 2001-11-28 | 2010-10-21 | THE PROCTER & GAMBLE COMPANY | Composiciones de dentifrico. |
US8071076B2 (en) | 2002-05-28 | 2011-12-06 | Oral Health Clinical Services Llc | Oral lubricating and stain retarding compositions |
EP1575444A1 (en) | 2002-11-14 | 2005-09-21 | Smithkline Beecham Corporation | Controlled-dissolving polymeric device for the oral cavity |
DE602004025824D1 (de) * | 2003-09-08 | 2010-04-15 | Fmc Biopolymer As | Gel-schaum auf biopolymer-basis |
JP2006182705A (ja) | 2004-12-28 | 2006-07-13 | Lion Corp | 歯牙貼付用製品及び口腔ケア物質の供給方法 |
WO2006136196A1 (en) | 2005-06-21 | 2006-12-28 | V. Mane Fils | Gellan seamless breakable capsule and process for manufacturing thereof |
GB0605634D0 (en) | 2006-03-21 | 2006-05-03 | Biofilm Ltd | Breath deodoriser |
BRPI0717149B1 (pt) | 2006-09-29 | 2016-02-16 | Procter & Gamble | composição oral contendo redes de gel e processo para o preparo da mesma. |
BRPI0622151B1 (pt) * | 2006-10-02 | 2022-06-07 | The Procter & Gamble Company | Composições estanosas para tratamento oral e método de acentuação da eficácia terapêutica das ditas composições |
JP5784878B2 (ja) | 2007-03-07 | 2015-09-24 | ノバルティス アーゲー | 経口投与可能なフィルム |
KR100937625B1 (ko) * | 2007-08-10 | 2010-01-20 | 주식회사 제닉 | 가용성 웹 공극필름 및 이의 제조방법 |
US8765155B2 (en) | 2007-08-30 | 2014-07-01 | Colgate-Palmolive Company | Oral care strip or tape and methods of use and manufacture thereof |
WO2009088229A2 (ko) * | 2008-01-09 | 2009-07-16 | Lg Household & Health Care Ltd. | 고형의 구강 위생 조성물 및 이의 제조방법 |
US8728446B2 (en) | 2008-06-03 | 2014-05-20 | I Did It, Inc. | Oral hygiene tablets and capsules for direct oral delivery of active ingredients |
TWI404544B (zh) | 2008-08-11 | 2013-08-11 | Colgate Palmolive Co | 含珠粒之口腔保健組成物 |
WO2010068444A2 (en) | 2008-11-25 | 2010-06-17 | The Procter & Gamble Company | Whitening composition with fused silica |
GB0908433D0 (en) * | 2009-05-15 | 2009-06-24 | Glaxo Group Ltd | Movel composition |
KR101074271B1 (ko) | 2009-06-25 | 2011-10-17 | (주)차바이오앤디오스텍 | 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름 |
US8113729B2 (en) | 2009-07-08 | 2012-02-14 | Dental Development Systems, Llc | Toothpaste droplets |
US9750669B2 (en) | 2009-07-08 | 2017-09-05 | Wayne R Solan | Toothpaste droplets |
US8827583B2 (en) | 2009-07-08 | 2014-09-09 | Dental Development Systems, Llc | Toothpaste droplets |
WO2011014401A2 (en) | 2009-07-30 | 2011-02-03 | The Procter & Gamble Company | Oral care articles and methods |
CA2775444C (en) * | 2009-10-29 | 2015-04-21 | Colgate-Palmolive Company | Dentifrice comprising stannous fluoride plus zinc citrate and low levels of water |
WO2012003365A1 (en) | 2010-07-02 | 2012-01-05 | The Procter & Gamble Company | Filaments comprising an ingestible active agent nonwoven webs and methods for making same |
PL2588091T3 (pl) * | 2010-07-02 | 2020-08-24 | The Procter & Gamble Company | Sposoby dostarczania medycznej substancji czynnej poprzez podawanie wyrobów do higieny osobistej zawierających filament |
MX2012015169A (es) | 2010-07-02 | 2013-05-09 | Procter & Gamble | Filamentos que comprenden un agente activo sin perfume, tramas de tela no tejida y métodos para elaborarlos. |
WO2012003319A2 (en) | 2010-07-02 | 2012-01-05 | The Procter & Gamble Company | Filaments comprising an active agent nonwoven webs and methods for making same |
CA2803625C (en) | 2010-07-02 | 2016-04-05 | The Procter & Gamble Company | Filaments comprising an active agent nonwoven webs and methods for making same |
CN103003476B (zh) | 2010-07-02 | 2016-02-10 | 宝洁公司 | 纤维网材料以及用于制造纤维网材料的方法 |
BR112013000044B1 (pt) | 2010-07-02 | 2022-01-04 | The Procter & Gamble Company | Método para a distribuição de agentes ativos a artigos de tecido ou superfícies duras |
CA2803371C (en) | 2010-07-02 | 2016-04-19 | The Procter & Gamble Company | Process for making films from nonwoven webs |
US20120175273A1 (en) * | 2011-01-07 | 2012-07-12 | Scott Jacobs | Toothpaste tablet |
CA2860647C (en) | 2012-01-04 | 2022-06-14 | The Procter & Gamble Company | Active containing fibrous structures with multiple regions having differing densities |
CN106968050B (zh) | 2012-01-04 | 2019-08-27 | 宝洁公司 | 具有多个区域的含活性物质纤维结构 |
GB2498265B (en) | 2012-01-04 | 2015-04-08 | Procter & Gamble | Fibrous structures comprising particles and methods for making same |
US20150342844A1 (en) | 2012-04-25 | 2015-12-03 | Elevate Oral Care, Llc | Fluoride varnish |
WO2013171164A1 (en) * | 2012-05-14 | 2013-11-21 | EJP Pharmaceutical ApS | Compositions and formulations for the treatment of halitosis |
US10123953B2 (en) | 2012-06-21 | 2018-11-13 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antimicrobials |
US20170216155A1 (en) | 2012-10-10 | 2017-08-03 | Rita Maloney | Tooth bean systems |
WO2014103667A1 (ja) | 2012-12-28 | 2014-07-03 | 日本バイリーン株式会社 | 機能性不織布及びその製造方法 |
JP6135206B2 (ja) | 2013-03-12 | 2017-05-31 | ライオン株式会社 | フィルム状口腔用組成物 |
AU2014250947B2 (en) | 2013-04-10 | 2016-07-14 | The Procter & Gamble Company | Oral care compositions containing polyorganosilsesquioxane particles |
US9656102B2 (en) | 2013-04-23 | 2017-05-23 | Rita Vaccaro | Thin film toothpaste strip |
US20160324741A1 (en) * | 2013-06-10 | 2016-11-10 | The Procter & Gamble Company | Oral Compositions Containing Zinc |
CN103356811B (zh) | 2013-06-18 | 2015-02-18 | 荆州市荆康生物科技有限公司 | 一种口腔咀嚼片及其制备方法与应用 |
ES2436221B1 (es) * | 2013-07-10 | 2014-10-13 | José María Martínez Marquina | Dentífrico sólido en barra |
RU2690000C2 (ru) | 2013-09-06 | 2019-05-30 | Дзе Проктер Энд Гэмбл Компани | Капсулы, содержащие водорастворимые волокнистые материалы стенок, и способы их изготовления |
MX383769B (es) | 2013-09-06 | 2025-03-14 | Procter & Gamble | Bolsitas que comprenden materiales de pared de película perforados y métodos para su fabricación. |
EP3572572B1 (en) | 2013-12-09 | 2021-01-20 | The Procter & Gamble Company | Method for printing a graphic on a fibrous structure |
MX383756B (es) * | 2013-12-24 | 2025-03-14 | Univ Melbourne | Composiciones estannosas estabilizadas. |
CN106414708A (zh) | 2014-01-24 | 2017-02-15 | 宝洁公司 | 包含含有微生物的纤维元件的纤维网及其制备方法 |
RU2674126C2 (ru) | 2014-04-22 | 2018-12-04 | Дзе Проктер Энд Гэмбл Компани | Филаменты и волокнистые структуры, их содержащие |
JP6362226B2 (ja) | 2014-04-22 | 2018-07-25 | ザ プロクター アンド ギャンブル カンパニー | 溶解性固体構造物の形態の組成物 |
WO2015172348A1 (en) | 2014-05-15 | 2015-11-19 | The Procter & Gamble Company | Dentifrice compositions having dental plaque mitigation or improved fluoride uptake |
KR20170049559A (ko) | 2014-10-10 | 2017-05-10 | 더 프록터 앤드 갬블 캄파니 | 용해성 섬유질 구조체 및 이의 제조 방법 |
ES2844595T3 (es) | 2014-10-10 | 2021-07-22 | Procter & Gamble | Estructuras fibrosas solubles con orificios |
US20160135657A1 (en) | 2014-10-17 | 2016-05-19 | Porex Corporation | Disposable Porous Cleaning Devices and Methods |
RU2683101C1 (ru) | 2015-03-04 | 2019-03-26 | Дзе Проктер Энд Гэмбл Компани | Волокнистые элементы, волокнистые структуры и продукты, содержащие сдерживающий агент, и способы их изготовления |
CN107427423A (zh) * | 2015-03-30 | 2017-12-01 | 荷兰联合利华有限公司 | 固体口腔护理组合物 |
EP3373892B1 (en) | 2015-11-13 | 2021-04-28 | The Procter & Gamble Company | Dentifrice compositions with dual fluoride source with improved fluoride uptake |
EP3373901B2 (en) | 2015-11-13 | 2025-01-15 | The Procter & Gamble Company | Dentifrice compositions with improved fluoride uptake |
WO2017127258A1 (en) | 2016-01-21 | 2017-07-27 | The Procter & Gamble Company | Fibrous elements comprising polyethylene oxide |
US11697906B2 (en) | 2017-01-27 | 2023-07-11 | The Procter & Gamble Company | Active agent-containing articles and product-shipping assemblies for containing the same |
US11697904B2 (en) | 2017-01-27 | 2023-07-11 | The Procter & Gamble Company | Active agent-containing articles that exhibit consumer acceptable article in-use properties |
US20180216288A1 (en) | 2017-01-27 | 2018-08-02 | The Procter & Gamble Company | Active Agent-Containing Articles that Exhibit Consumer Acceptable Article In-Use Properties |
US11697905B2 (en) | 2017-01-27 | 2023-07-11 | The Procter & Gamble Company | Active agent-containing articles that exhibit consumer acceptable article in-use properties |
US10975340B2 (en) | 2017-05-16 | 2021-04-13 | The Procter & Gamble Company | Active agent-containing fibrous structure articles |
US10975339B2 (en) | 2017-05-16 | 2021-04-13 | The Procter & Gamble Company | Active agent-containing articles |
US10975338B2 (en) | 2017-05-16 | 2021-04-13 | The Procter & Gamble Company | Active agent-containing three-dimensional articles |
US20190133893A1 (en) | 2017-07-20 | 2019-05-09 | Oscar E. Recio Saucedo | Tooth Paste Gummy |
US10835455B2 (en) | 2018-05-14 | 2020-11-17 | The Procter & Gamble Company | Oral care compositions comprising metal ions |
BR112021024255A2 (pt) | 2019-06-13 | 2022-01-11 | Procter & Gamble | Kits compreendendo composições para tratamento bucal de dose unitária |
-
2019
- 2019-05-14 US US16/411,180 patent/US10835455B2/en active Active
- 2019-05-14 US US16/411,178 patent/US20190343732A1/en not_active Abandoned
- 2019-05-14 CA CA3100060A patent/CA3100060C/en active Active
- 2019-05-14 EP EP19728193.4A patent/EP3793515A1/en active Pending
- 2019-05-14 AU AU2019269408A patent/AU2019269408B9/en active Active
- 2019-05-14 BR BR112020023002-2A patent/BR112020023002A2/pt not_active Application Discontinuation
- 2019-05-14 CA CA3099957A patent/CA3099957C/en active Active
- 2019-05-14 MX MX2020011409A patent/MX385757B/es unknown
- 2019-05-14 CN CN201980032233.0A patent/CN112135668B/zh active Active
- 2019-05-14 JP JP2020562582A patent/JP7112520B2/ja active Active
- 2019-05-14 CN CN201980032394.XA patent/CN112135600B/zh active Active
- 2019-05-14 BR BR112020022117-1A patent/BR112020022117A2/pt not_active Application Discontinuation
- 2019-05-14 CA CA3097222A patent/CA3097222A1/en active Pending
- 2019-05-14 MX MX2020011413A patent/MX2020011413A/es unknown
- 2019-05-14 US US16/411,181 patent/US10932996B2/en active Active
- 2019-05-14 AU AU2019270965A patent/AU2019270965B2/en active Active
- 2019-05-14 US US16/411,176 patent/US10821056B2/en active Active
- 2019-05-14 JP JP2020562594A patent/JP7110394B2/ja active Active
- 2019-05-14 MX MX2020011410A patent/MX385759B/es unknown
- 2019-05-14 WO PCT/US2019/032126 patent/WO2019222153A1/en unknown
- 2019-05-14 CA CA3100054A patent/CA3100054C/en active Active
- 2019-05-14 EP EP19731816.5A patent/EP3793507A1/en active Pending
- 2019-05-14 JP JP2020562605A patent/JP7114742B2/ja active Active
- 2019-05-14 WO PCT/US2019/032084 patent/WO2019222124A1/en unknown
- 2019-05-14 EP EP19729414.3A patent/EP3793692A1/en active Pending
- 2019-05-14 AU AU2019270966A patent/AU2019270966B2/en active Active
- 2019-05-14 AU AU2019270967A patent/AU2019270967B2/en active Active
- 2019-05-14 MX MX2020011412A patent/MX385758B/es unknown
- 2019-05-14 WO PCT/US2019/032086 patent/WO2019222126A1/en unknown
- 2019-05-14 CN CN201980032399.2A patent/CN112118893A/zh active Pending
- 2019-05-14 WO PCT/US2019/032085 patent/WO2019222125A1/en unknown
- 2019-05-14 CN CN201980032396.9A patent/CN112118823B/zh active Active
- 2019-05-14 JP JP2020562606A patent/JP2021523142A/ja active Pending
- 2019-05-14 EP EP19728194.2A patent/EP3793691A1/en active Pending
-
2020
- 2020-09-01 US US17/008,684 patent/US11944694B2/en active Active
-
2021
- 2021-01-19 US US17/151,897 patent/US20210137797A1/en active Pending
- 2021-03-15 US US17/201,023 patent/US20210196581A1/en not_active Abandoned
- 2021-05-18 US US17/323,050 patent/US20210267851A1/en active Pending
-
2022
- 2022-07-22 JP JP2022117103A patent/JP2022141877A/ja active Pending
- 2022-07-27 JP JP2022119379A patent/JP2022141922A/ja not_active Ceased
- 2022-10-28 JP JP2022173497A patent/JP2023011776A/ja active Pending
- 2022-11-17 AU AU2022271450A patent/AU2022271450B2/en active Active
-
2023
- 2023-04-03 US US18/130,092 patent/US20230248620A1/en active Pending
-
2024
- 2024-02-28 US US18/589,567 patent/US20240197578A1/en active Pending
- 2024-03-12 AU AU2024201620A patent/AU2024201620B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1713886A (zh) * | 2002-11-26 | 2005-12-28 | 宝洁公司 | 可咀嚼的固体单位剂型和可用于将活性剂递送到牙齿咬合面的方法 |
CN104069013A (zh) * | 2006-10-02 | 2014-10-01 | 宝洁公司 | 亚锡口腔护理组合物 |
CN103282015A (zh) * | 2010-07-02 | 2013-09-04 | 宝洁公司 | 包含活性剂的可溶性纤维网结构制品 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112118823B (zh) | 包含氟离子的口腔护理组合物 | |
JP7420837B2 (ja) | 単位用量口腔ケア組成物を含むキット | |
US20240225968A1 (en) | Oral Care Compositions Comprising Metal Ions | |
BR112020023096B1 (pt) | Composições para tratamento bucal compreendendo íons metálicos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |